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 RESUMO 
O objetivo da pesquisa foi estimar a prevalência de sinais e sintomas 
locais e sistêmicos durante a erupção dos dentes decíduos. Realizou-se 
busca eletrônica nas bases de dados: LILACS, PubMed, ProQuest, 
Scopus e Web of Science e busca parcial da literatura cinzenta através 
do Google Scholar. As listas de referências dos estudos incluídos foram 
analisadas buscando artigos que inadvertidamente tenham sido 
excluídos nas buscas eletrônicas. Baseado na estratégia PECOS, foram 
incluídos estudos observacionais que verificaram a ocorrência de sinais 
e sintomas durante a erupção dos dentes decíduos através de relato de 
sintomas pelos pais e medida de temperatura corporal, além da análise 
clínica do dente em erupção, em crianças de 0-36 meses. A extração dos 
dados dos artigos selecionados foi realizada por dois revisores de forma 
independente. As informações foram conferidas para confirmar a 
precisão. O processo de seleção ocorreu em duas fases. Do total de 
1.179 documentos identificados, 16 estudos foram incluídos. A análise 
qualitativa foi realizada através da avaliação do risco de viés dos estudos 
incluídos, enquanto a síntese quantitativa foi realizada através de meta-
análise. A heterogeneidade encontrada entre os estudos nas meta-
análises variou de 93,01 a 99,75% (p<0,0001), foi usado modelo 
aleatório. A prevalência geral de sinais e sintomas durante a erupção dos 
dentes decíduos em crianças entre 0-36 meses foi de 70,5% (amostra 
total = 3506, 95% IC 54,19 a 84,62). Inflamação gengival (86,81%), 
irritabilidade (68,19%) e aumento de salivação (55,72%) foram os mais 
frequentes. Alguns estudos apresentaram: ausência de relato sobre os 
fatores de confundimento, uso de medidas subjetivas e exames em 
intervalos longos. Concluiu-se que a prevalência de sinais e sintomas 
durante a erupção dos dentes decíduos foi alta. Não houve a ocorrência 
de febre durante a erupção dos dentes decíduos, mas um leve aumento 
da temperatura corporal. 
Palavras-chave: Erupção Dentária. Sinais e Sintomas. Dente Decíduo. 
Revisão. 
  
  
 ABSTRACT 
Symptoms associated with the primary tooth eruption have been 
extensively studied but it is still controversial. The objective of the study 
was to to assess the occurrence of local and systemic signs and 
symptoms during primary tooth eruption through a systematic review. 
LILACS, PubMed, ProQuest, Scopus and Web of Science were 
searched. A partial grey literature search was taken using Google 
Scholar and the reference lists of the included studies were scanned. 
Observational studies assessing the association of eruption of primary 
teeth with local and systemic signs and symptoms in children aged 0-36 
months were included. Two authors independently collected the 
information from the selected articles. Information was crosschecked 
and confirmed for its accuracy. A total of 1,179 papers were identified 
and after a 2-phase selection 16 studies were included. The qualitative 
analysis was performed by assessing the risk of bias of the included 
studies, while quantitative synthesis was performed by meta-analysis. 
The heterogeneity found among studies in the meta-analysis ranged 
from the 93.01 to 99.75% (p <0.0001), a random model was used. 
Overall prevalence of signs and symptoms occurring during primary 
tooth eruption in children between 0-36 months was 70.5% (total 
sample=3506 95% CI 54,19 a 84,62). Gingival inflammation (86.81%), 
irritability (68.19%) and drooling (55.72%) were the most frequent ones. 
As limitations, different general symptoms were considered among 
studies. Some studies presented: lack of confounding factors, use of 
subjective measures and examinations in long intervals. It was 
concluded that the prevalence of signs and symptoms during the 
eruption of primary teeth was high. There was no occurrence of fever 
during the eruption of primary teeth, but a slight increase of body 
temperature. 
Keywords: Teething. Tooth eruption. Signs. Symptoms. Primary tooth. 
Review. 
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1 CONTEXTUALIZAÇÃO 
O primeiro ano representa um período de grandes transformações 
na vida das crianças e de suas famílias. Mudanças no comportamento 
das crianças são esperadas e fazem parte do seu crescimento e 
amadurecimento. É nessa fase que começa a erupção dos dentes 
decíduos. A erupção do primeiro dente geralmente acontece por volta do 
sexto mês e os últimos são esperados até os 30 meses. 
A erupção dental é um processo fisiológico normal, onde o dente 
se movimenta da sua posição de formação dentro do osso alveolar até o 
rompimento gengival na cavidade bucal (MARKS; SCHROEDER, 
1996; CRADDOCK; YOUNGSON, 2004). Pode ser dividida em três 
fases: 1) Crescimento folicular - a cripta do dente em desenvolvimento 
expande simetricamente nos sentidos vertical e mésio-distal. Esta 
aparente imobilidade persiste até que toda a coroa seja calcificada; 
(STEEDLE; PROFFIT, 1985); 2) Movimento pré-eruptivo - movimento 
intraósseo com a formação das raízes na medida em que o dente começa 
um período de erupção rápida na direção oclusal através dos processos 
de reabsorção dos tecidos sobrepostos, criando uma caminho eruptivo 
conforme se aproxima do rompimento gengival; (CAHILL; MARKS, 
1980); e, finalmente, 3) Movimento pós-eruptivo - onde o dente se move 
da posição de rompimento inicial até o plano oclusal (PROFFIT; 
FRAZIER-BOWERS, 2009). 
Embora faça parte do desenvolvimento infantil normal, a relação 
entre a erupção dos dentes decíduos e a saúde geral das crianças ainda é 
controversa (HONIG, 1975; GIBBONS; HEBDON, 1991, DALLY, 
1996, MACKNIN et al., 2000, MCINTYRE; MCINTYRE, 2002, 
ROMERO-MAROTO; SÁEZ-GÓMEZ, 2009, OWAIS; ZAWAIDEH, 
BATAINEH, 2010, ZAKIRULLA; ALLAHBAKSH, 2011). 
Há a crença, entre os pais, de que a erupção dos dentes decíduos 
está associada com alterações comportamentais e sistêmicas 
(CASTIGLIA, 1992, WAKE; HESKETH; ALLEN, 1999, BAYKAN, et 
al., 2004, SARRELL et al., 2005, FELDENS, 2010; KAKATKAR et al., 
2012). Nesse período de dois anos que corresponde à fase de erupção 
dental, há grandes alterações nos hábitos das crianças. Os padrões de 
sono e de alimentação sofrem transformações. Algumas crianças 
manifestam ansiedade de separação dos pais. Há, ainda, os quadros de 
enfermidades. Muitas vezes essas alterações no comportamento causam 
angústia e confusão nos pais, que podem acabar relacionando tais 
eventos, que levam à noites de choro e sem dormir, ao processo de 
erupção dental. Assim, o momento da erupção dental pode ser 
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preocupante para os pais, principalmente quando se trata do primeiro 
filho. Muitos pais não sabem como identificar os sinais da erupção 
dental no seu filho (PLUTZER; SPENCER; KEIRSE, 2011, KOZUCH; 
PEACOCK; D’AURIA, 2015).  
Em uma tentativa de aliviar os sintomas da criança, os pais 
podem recorrer a medicamentos orais ou tópicos sem orientação 
profissional (SEWARD, 1969). Em alguns países africanos, as crenças 
culturais podem levar a práticas como “gum lancing”, ou corte gengival, 
que é referido como o ato de cortar a gengiva que recobre o dente em 
erupção, realizado geralmente por pais ou avós da criança, como um 
remédio para a "diarreia da dentição", com graves consequências que 
vão desde desidratação grave até sepse generalizada (OLABU et al., 
2013). 
Muitos profissionais da saúde também acreditam na associação 
entre sinais e sintomas e a erupção dos dentes decíduos. Pesquisas com 
pediatras e outros profissionais responsáveis pela saúde das crianças 
revelam que as crenças sobre os sintomas são comuns e variam pouco 
entre o grupo profissional estudado (HONIG, 1975, WAKE; 
HESKETH, 2002, FARACO JUNIOR et al., 2008). Falta de apetite, 
diarreia e febre, frequentemente associados com a erupção dental podem 
estar relacionados à outras alterações sistêmicas e até mesmo à doenças 
mais graves (SWANN, 1979) . É importante que os profissionais da 
saúde sejam capazes de informar adequadamente aos pais o que pode ser 
esperado do processo de erupção dental a fim de evitar que doenças 
mais graves sejam diagnosticadas tardiamente. Alguns estudos tendem a 
considerar que a erupção dental causa poucos sintomas, se houver, e que 
nenhuma doença deveria ser atribuída à erupção dental (JABER; 
COHEN; MOR, 1992, WAKE; HESKETH; LUCAS, 2000).  
Investigações relacionadas às alterações gengivais locais nessa 
fase através da biópsia a partir da membrana mucosa que cobre o dente 
antes do rompimento e em torno do dente que já apresenta perfuração 
gengival, mostrou a presença de degenerações na mucosa e células 
inflamatórias em ambos os casos. Não houve diferença histológica entre 
crianças com ou sem alterações sistémicas (SOLIMAN, SOLIMAN, 
1978). Exames da cor da mucosa das mesmas regiões não revelaram 
qualquer correlação evidente com alterações patológicas (TASANEN, 
1969). Da mesma forma, foi observado um aumento dos níveis de 
citocinas inflamatórias no fluido crevicular gengival dos dentes  em 
processo de erupção (SHAPIRA, et al., 2003). 
Tigue e Roe (2007) conduziram uma revisão da literatura para 
identificar a existência de quaisquer sinais e sintomas patognomônicos  
21 
da erupção dental. Embora a análise tenha mostrado uma variedade de 
sintomas que podem ocorrer simultaneamente, não houve evidências 
que sugerissem a existência de quaisquer sinais ou sintomas que 
pudessem sugerir a erupção dental.  
A Academia Americana de Odontopediatria em suas Diretrizes 
sobre Saúde Bucal Infantil (DENTISTRY AAOP, 2014) apresenta 
orientações de que a erupção dos dentes decíduos leva ao desconforto 
local, alteração de humor com irritação e aumento da salivação. O 
tratamento sugerido inclui analgésicos orais e mordedores. 
O uso de anestésicos géis para aplicação tópica nas gengivas 
durante a erupção dos dentes decíduos não é recomendado por 
representar risco à saúde (SOOD; SOOD, 2010).  Os agentes anestésicos 
locais comumente encontrados nessas preparações representam risco de 
desenvolvimento de reações de hipersensibilidade e efeitos adversos 
graves (TSANG, 2011). Em 2011, a Agência Governamental Americana 
do Departamento de Saúde, FDA (US-Food and Drug Administration) 
advertiu que o uso tópico de géis de benzocaína para a erupção dos 
dentes decíduos tem o potencial de causar methaemaglobinaemia. Em 
2014, a FDA recomendou o não uso de solução oral de lidocaína por 
crianças pequenas devido ao risco de deglutição acidental. Essa prática 
pode resultar em convulsões, lesão cerebral grave e problemas  
cardíacos (FDA, 2014). 
Assim, ao conhecer as implicações que a erupção dental tem 
nesse período de vida da criança, esse trabalho tem o propósito de 
contribuir para esclarecer quanto a compreensão e conduta dos pais em 
relação às possíveis alterações de comportamento que a criança pode 
manifestar durante a erupção dos dentes decíduos. 
Dessa forma, a proposta desse estudo foi realizar uma revisão 
sistemática para responder a seguinte pergunta focada: “Em crianças 
entre zero e 36 meses de idade, há a ocorrência de sinais e sintomas 
locais e sistêmicos durante a erupção dos dentes decíduos?” 
Devido à importância das publicações para o aprimoramento da 
pesquisa e para o Programa de Pós Graduação em Odontologia, esta 
dissertação foi desenvolvida e está apresentada em forma de artigo a ser 
submetido à revista Pediatrics. 
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2 OBJETIVO 
2.1 OBJETIVO GERAL 
Pretende-se, através de uma revisão sistemática da literatura, 
verificar a prevalência de sinais e sintomas locais e sistêmicos durante a 
erupção dos dentes decíduos. 
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3 ARTIGO 
Artigo a ser submetido à revista: 
Pediatrics 
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ABSTRACT 
Context: Symptoms associated with the primary tooth eruption have 
been extensively studied but it is still controversial.  
Objective: To assess the occurrence of local and systemic signs and 
symptoms during primary tooth eruption.  
Data Sources: LILACS, PubMed, ProQuest, Scopus and Web of 
Science were searched. A partial grey literature search was taken using 
Google Scholar and the reference lists of the included studies were 
scanned.  
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Study Selection: Observational studies assessing the association of 
eruption of primary teeth with local and systemic signs and symptoms in 
children aged 0-36 months were included. 
Data Extraction: Two authors independently collected the information 
from the selected articles. Information was crosschecked and confirmed 
for its accuracy. 
Results:  A total of 1,179 papers were identified and after a 2-phase 
selection process 16 studies were included. The registration of 
symptoms revealed significant heterogeneity. Ten studies had data 
enough to conduct meta-analysis. Overall prevalence of signs and 
symptoms occurring during primary tooth eruption in children between 
0-36 months was 70.5% (total sample=3506). Gingival inflammation 
(86.81%), irritability (68.19%) and drooling (55.72%) were the most 
frequent ones. 
Limitations: Different general symptoms were considered among 
studies. Some studies presented: lack of confounding factors, no clear 
definition of the diagnostic methods, use of subjective measures and 
examinations in long intervals.  
Conclusions: There is evidence of the occurrence of signs and 
symptoms during primary tooth eruption. For body temperature 
analyses, it can lead to a rise in temperature, but it was not characterized 
as fever.  
INTRODUCTION 
Tooth eruption is a physiological process in which teeth move 
from its development position within the alveolar bone to break the gum 
towards the oral cavity.
1
 Nevertheless, this mechanism and the source of 
the eruptive force has not been established nor completely understood.
2
 
Despite being a natural process of child development, the impacts of 
primary tooth eruption on the overall health of children are still 
controversial. Recent studies have suggested that tooth eruption could be 
accompanied by different benign symptoms, such as increased 
salivation, irritability, loss of appetite for solid foods and rise in body 
temperature.
3,4,5,6,7,8,9,10,11 
Moreover, the eruption of primary teeth has been assumed among 
parents to be associated with behavioral and systemic 
changes.
12,13,14,15,16,17 
The period of time that tooth eruption occurs can 
be very frustrating and stressful for parents, especially when it happens 
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to their first offspring. Many parents do not know how to identify the 
signs of tooth eruption in their children and, therefore, do not feel 
confident to relieve the discomfort of the child.
18,19
 Likewise, many 
health professionals also believe that there is an association between 
some signs and symptoms and the eruption of primary teeth. Surveys 
with pediatricians and other child health professionals showed that these 
beliefs are common.
3,20,21
 The use of this diagnostic label may lead 
either parents not manage a likely illness
10
 or the doctors to ignore 
significant symptoms and fail in diagnoses.
22
 
Nevertheless, consistent evidences on the association of tooth 
eruption and general signs and symptoms are rather low and out of date. 
In a review conducted by Tighe et al
23
 in 2007 to identify the existence 
of any pathognomonic sign and symptom of dental eruption, a variety of 
symptoms that may occur simultaneously with the tooth eruption was 
demonstrated and no evidence suggested the existence of any signs or 
symptoms that could predict the tooth eruption.  
Thus, the purpose of this systematic review was to answer the 
following focused question: “In children aged 0 up to 36 months, are 
there local or systemic signs and symptoms during the eruption of the 
primary teeth?” 
METHODS 
This systematic review was oriented following the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
protocol.
24
 
Protocol Registration 
The systematic review protocol was recorded at the International 
Prospective Register of Systematic Reviews (PROSPERO)
25
 under 
number CRD 42015020822.  
Eligibility criteria 
Inclusion criteria 
Observational studies assessing the occurrence of local and 
systemic signs and symptoms during the spontaneous eruption of 
primary teeth in healthy children aged between 0 and 36 months, by 
means of either clinical examination or a questionnaire directed to the 
parents or health care professionals, were included. The local and 
systemic signs and symptoms evaluated were all reported complications 
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related to teething described in the studies (e.g., decreased appetite, 
diarrhea, drooling, fever, inflammation, swelling, vesicles or ulceration 
of the gum, irritability, rash, rhinorrhea, sleeping disturbances, 
vomiting). 
Exclusion criteria  
Exclusion of the studies was performed in two phases. In phase 
one (titles and abstracts) the exclusion criteria were as follows: 1 - 
Studies conducted in children aged over 36 months old; 2 - Reviews, 
letters, conference abstracts; 3 - Studies in which the sample included 
genetic syndromic patients (e.g., Down syndrome, craniofacial 
anomalies, neuromuscular disorders, etc.); 4 - Studies in which the 
sample included malignancies, malnutrition and chronic diseases; 5 - 
Studies in which the sample included non-spontaneous eruption of 
primary teeth; 6 - Studies in which the eruption of primary teeth was not 
the primary outcome. Besides the six cited criteria, in phase two (full-
text) the following exclusion criteria were added: 7 - Studies in which 
clinical exam was not performed by a health care professional and, 8- 
Articles that evaluated the same sample. 
Information sources and search strategies 
A systematic search was conducted on the following electronic 
databases: Latin American and Caribbean Health Sciences (LILACS), 
PubMed, ProQuest Dissertations and Theses Database, Scopus and Web 
of Science, for titles and abstracts relevant to the research question. The 
syntax has been adapted to each database (Appendix 1). A partial grey 
literature search was taken using Google Scholar limited to the first 100 
most relevant articles published in the past 5 years. The reference lists of 
the included studies were scanned to identify additional studies of 
relevance. All references were managed by reference manager software 
EndNote® Basic (Thomson Reuters, New York, EUA) and duplicate 
hits were removed. The end search date was May 6th, 2015. No 
language or date restrictions were applied. 
Study Selection 
The selection occurred in a 2-phase process in order to minimize 
bias. In phase 1, studies were independently screened by 2 reviewers 
(CM, MB) based on the titles and, if available, the abstracts derived 
from the search. Any study that clearly did not fulfill the inclusion 
criteria was discarded. In phase 2, the full text of relevant papers was 
retrieved for further analysis by the same 2 reviewers (CM, MB) and 
29 
was either included or excluded in the review on the basis of the 
eligibility criteria. Disagreements of inclusion/exclusion were handled 
through discussion and the third reviewer (MC) was consulted to make a 
final decision. 
Data Collection Process 
Two authors (CM, MB) independently collected the required 
information from the selected articles. After, all the collected 
information was crosschecked and confirmed for its accuracy. Again, 
any disagreement was resolved by discussion and mutual agreement 
between the authors. The third author (MC) was involved, when 
required, to make a final decision. 
Data Items 
For all of the included studies the following structured 
information was recorded: study characteristics (authors, year of 
publication, country, study design, setting), population characteristics 
(sample size, age of participants), intervention characteristics (type of 
diagnostic approach - clinical exam, body temperature, questionnaire) 
and, finally, outcome characteristics (assessed teeth, symptoms, mean 
temperature in non-eruption days, mean temperature in eruption days 
and conclusions pertaining to the occurrence of local and systemic signs 
and symptoms during the eruption of primary teeth). Authors were 
contacted for further details when relevant information was not reported 
or there was doubt remaining about duplicate publication.  
Risk of Bias in Individual Studies 
Two reviewers (CM, MB) independently assessed the 
methodological quality of the included studies, using the “Quality in 
Prognosis Studies Tool” (QUIPS).
26
 The QUIPS tool comprises 6 
domains: Study Participation, Study Attrition, Prognostic Factors 
Measurement, Outcome Measurement, Study Confounding and 
Statistical Analysis and Reporting to guide ratings of high, moderate or 
low risk of bias. Disagreements were resolved through consensus when 
possible, or a third reviewer (MC) made the final decision. 
Summary Measures  
Presence of local and systemic signs and symptoms and 
differences in body temperature during the eruption of primary teeth 
were considered the main outcomes. For body temperature, the 
threshold point was considered according to a recent meta-analysis on 
30 
accuracy of infrared tympanic thermometry,
27
 between 37.4°C to 37.8°C 
for tympanic temperature and 38.0°C for rectal temperature. Any type of 
related outcome measurement was computed (categorical variables and 
continuous variables). 
Synthesis of results 
A meta-analysis was planned within the studies presenting 
enough data. The occurrence of signs and symptoms of the eruption of 
primary teeth was analyzed by two types of meta-analysis, for fixed and 
random effects following the appropriate Cochrane Guidelines.
28
 Meta-
analysis was performed with the aid of MedCalc Statistical Software 
version 14.8.1 (MedCalc Software, Ostend, Belgium). Heterogeneity 
was calculated by inconsistency indexes (I
2
), and a value greater than 
50% was considered an indicator of substantial heterogeneity between 
studies.
29
 The significance level was set at 5%. 
Risk of bias across studies 
Clinical heterogeneity (differences in participants, interventions 
and outcomes) and methodological heterogeneity (study design, risk of 
bias) were explored.  
RESULTS 
Study Selection 
The search identified 1,318 citations across 5 databases. After 
duplicates removal, 1,179 papers were screened in phase 1. A total of 65 
papers met criteria for full-text screening. Additionally, 100 citations 
from Google Scholar were considered. From these, 4 further studies met 
the inclusion criteria. A hand search on the reference lists was 
performed for any study that might have been inadvertently missed by 
the electronic search procedures and 6 additional references were 
identified. Based on exclusion criteria for phase 2 (full-text screening), 
59 articles were excluded. Two articles evaluated the same sample and 
one was not found. The reasons for exclusion are compiled in a 
comprehensive list (Appendix 2). Therefore, 16 articles were selected 
for data collection with the aim of answering the review question. A 
flowchart of the process of identification and selection of studies is 
shown in Figure 1. 
Study Characteristics 
31 
The reviewed studies were conducted in 8 different countries: 
Australia,
10,30
 Brazil,
31,32,33
   Colombia,
34
 Finland,
35
 India,
36,37,38
 
Israel,
11,39,40
 Senegal
41
 and United States.
42,43
 The sample size ranged 
widely from 16
40
 to 1,165
32
 children. The search involved papers 
published between 1969
35,39
 to 2012.
38
 A summary of the study 
descriptive characteristics can be found in Table 1.  
Risk of Bias Within Studies 
The reported methodological quality of the included studies 
ranged between low and high risk of bias following QUIPS
26
 domains. 
Studies selected have shown to be heterogeneous considering bias, 7 
presented high
11,31,32,36,37,41,43 
risk of bias, 4 moderate
34,38,39,42
 and 5 
low.
10,30,33,35,40
 None of them fulfilled all the methodological criteria.  
Summarized assessment considering risk of bias can be found in Table 
2. Detailed results on the use of QUIPS
26
 tool in selected studies can be 
found in Appendix 3. 
Results of Individual Studies  
There were 2 researches that investigated exclusively local 
modifications.
30,36
 Other studies evaluated, besides general problems, 
local disturbances that could be involved on primary tooth 
eruption.
32,35,37,41
 Hulland et al
30
 observed that 85% of 128 teeth in 21 
children presented gingival hyperemia in the early stages of eruption. 
Chakraborty et al
36
 reported that anterior teeth erupted with less local 
signs than posterior.  King et al
43
 suggested that local signs could be 
confounded with oral herpetic infection.  
Shapira et al
40
 observed an increase in inflammatory cytokine 
levels in the gingival crevicular fluid surrounding erupting teeth, while 
Galili et al
39
 found that multiple eruption occurring at the same time 
were associated with diseases. Bengtson et al,
31 
Carpenter,
42
 Cunha et 
al
32 
and Yam et al
41 
observed that eruption of primary teeth were 
associated with symptoms. Kiran et al,
37
 Noor-Mohammed at al
38 
and 
Peretz at al
34
 found more symptoms associated with the eruption of the 
incisors. Tasanen
35
 evaluated that mild symptoms like sucking finger, 
rubbing gum an drooling increased during teething while Wake et al
10
 
reported that primary tooth eruption was not associated with symptoms. 
Jaber et al
11
 found that children erupted their teeth with fever and 
Ramos-Jorge at al
33  
that there was a slight rise in body temperature. 
The frequency of body temperature measurement varied between 
studies. In some of them daily registration could be assessed,
11,31,33,35,39
 
whereas in others every week day,
10
 twice a week
40
 or monthly.
42
 From 
32 
the studies in which type of thermometer and measurement were 
informed, four studies used rectal temperature
11,35,39,42
 and two 
tympanic.
10,33
 In studies that presented this data, the cutoff point to 
consider a child with high temperature ranged from 37.5ºC over a period 
of two days (rectal)
39
 to 39ºC in a single assessment (not informed).
34
 A 
summary of body temperature assessment can be found on Table 3. 
In relation of individual signs and symptoms, some investigations 
demonstrated that fever,
11,31,32,34,37,38,39,40,41,42
 drooling,
31,33,34,35,37,38,42
  
diarrhea,
31,32,33,34,37,38,41,42
 irritability,
31,32,33,37,40,42 
loss of 
appetite;
31,33,35,37,42
 sleeping problems
31,32,33,35,37
 and rhinorrhea
31,32,33,37,42
 
were associated with primary teeth eruption. In the opposite site, other 
studies exposed that the same symptoms – fever,
10,35
 irritability,
10
 sleep 
disturbances
10,39
 and loose stools
10,39
 - had no association with the 
eruption.  
Synthesis of results 
To easily interpret the results, the studies were clustered into 
overall prevalence of signs and symptoms (Figure 2) and separately 
prevalence for each individual sign or symptom (Figure 3). A total of 
ten studies were included in the meta-analysis. Eight studies had 
sufficient data to conduct meta-analysis
11,32,34,37,38,40,42,43
 of general 
prevalence of signs and symptoms. Another two studies were included 
in the meta-analysis of individual signs or symptoms. 
33,35
 
Because of the heterogeneity between the studies a random model 
was choosen.
44
 All the information about the meta-analysis of individual 
studies is described in Figure 2 and Appendix 4. The results from this 
meta-analysis revealed that the overall prevalence of signs and 
symptoms associated with primary tooth eruption in children between 0-
36 months was 70.5% (total sample=3506; Figure 2), where gingival 
irritation, irritability and drooling were the most frequent ones with 
86.81%, 68.19% and 55.72%, respectively. Additional information 
regarding the meta-analysis can be found on Appendix 4 and 5. 
Risk of bias across studies 
The studies were heterogeneous and had different designs. 
Analysis revealed that the weakness in methods was not considered 
important confounders capable to mask possible signs and symptoms 
related to other diseases that could occur simultaneously with primary 
tooth eruption.  
DISCUSSION 
33 
This systematic review investigated the available evidence about 
primary tooth eruption and local and systemic signs and symptoms. 
Currently, American Academy of Pediatric Dentistry guidelines have 
indications that eruption of primary teeth leads to local discomfort, 
irritation and drooling.
45
 
Parents follow the development of children and witness any 
change in behavior, mood or health. Thus, they can be helpful to assist 
the detection of related problems.
46
 Although cooperative, parents 
retrospectively reported symptoms associated with primary tooth 
eruption showed to be memory biased. In a retrospective study about 
parents’ beliefs related to primary tooth eruption, the mean number of 
symptoms reported per child was 11 while in the study sample the mean 
number was 8.
10
 Similarly, fever was reported five times more often in 
the retrospective than children experienced fever during teething period 
in the prospective study.
33
 Limitations of these studies are represented 
by the subjectivity of the parents’ observations. In this context, a study 
that had the collaboration of parents which daily measured children 
temperature, checked for tooth eruption and kept a daily log of 
symptoms, despite presented adequate methods, was excluded based on 
the criteria for this systematic review because children did not receive 
health professional examination during the follow-up. There was a 
significant association to tooth emergence: biting, drooling, gum 
rubbing, irritability, sucking, sleep awakenings, ear rubbing, rash on 
face, decreased appetite for solids, and slight temperature elevation.
6
 
Regarding the local signs, the most frequent was inflammation of 
the gum
36
 or gingival reddish (hyperemia),
30
 mostly in posterior teeth. 
The timing of eruption of the primary teeth (6 months onwards) 
coincides with age when babies start to explore the environment. In this 
phase, the introduction of the hands and objects into the mouth is 
normal; this, in turn, can bring harmful microorganisms and cause 
infection.
47
 Even sucking behavior, nutritive and nonnutritive, may lead 
to bruise or traumatize the gums causing inflammation.
48
 
Regarding the most frequent general symptoms during primary 
tooth eruption; irritability and drooling were the most observed followed 
by decreased appetite, sleeping problem, rhinorrhea, fever, diarrhea, 
rash and vomiting. Eruption was associated with fever,
40
 did not 
influence the body temperature
35
 or leads to a slight rise in body 
temperature.
33
 In contrast, symptoms that were not related to primary 
tooth eruption in the selected studies were in this sequence: 
sickness,
10,35,39
 sleeping disturbances,
10,39
 loose stools,
10,39
 drooling,
10,39  
vomiting
39  
 and fever.
10,35
 Three of most robust studies in this 
34 
systematic review showed that sucking finger, gum rubbing, daytime 
restlessness, loss of appetite,
35
 sleep disturbance, increased salivation, 
rash, rhinorrhea, diarrhea, irritability
33
 and coughing
40
  increased during 
teething.  
Another robust study,
10
 that accompanied 90 erupting teeth from 
21 children every weekday, reported that fever, mood disturbance, 
illness, sleeping disturbance, drooling, diarrhea, strong urine, red checks 
or rashes did not have association with primary tooth eruption.  
The stage of eruption considered to represent the day of eruption 
for the studies differed from the first day the edge of an incisor or a cusp 
of a molar could be seen or felt emerging through the gum,
10,33
 palpable 
with the finger nail;
35
 clinical crown of the tooth visible but not 
exceeding 3mm of exposure above the gingiva
34,37,38
 to any portion of 
the occlusal surface penetrated the gingiva.
39
 Besides that, the frequency 
of clinical exam varied from a single assessment in cross sectional 
studies to daily investigation in some prospective investigations. This is 
an important information since Hulland et al
30
 found out that the mean 
duration of primary tooth eruption from imminent eruption to 
completion of emergence phase was in an average rate of 0.7mm per 
month. Those studies that evaluated the eruption as the tooth crown 
visible through gingiva but not exceeding 3 mm or those that clinical 
examinations occurred in monthly intervals may have lost or 
overestimated some signs or symptoms.  
It seems that symptoms associated with primary tooth eruption 
decrease with age. Most manifestations were observed during the 
eruption of primary incisors
32,34,37,38
 or were studied only in 
incisors.
11,33,40
 Also there was a significant difference between the mean 
age at which eruptions were accompanied by disturbances (11.8 months) 
and the average age (14.8 months) at which teeth erupted without 
general disturbances. On the other hand, there seems to be an 
association between multiple eruption with fever and respiratory and 
alimentary illnesses that could be due to the stress that lead to the low 
resistance of the body against infections.
39
  
Accurate determination of body temperature is essential to 
diagnose fever.
49
 A recent systematic review investigating the accuracy 
of infrared tympanic thermometry used in the diagnosis of fever in 
children, disclosed that the accuracy of this kind of thermometer is high, 
using rectal measurement as the “gold standard”. Besides, as 
temperature measured by tympanic thermometry was always 0.6°C to 
0.2°C less than rectal temperature, the threshold of fever diagnosed by 
tympanic thermometry can be decreased. Therefore, if 38.0°C is the 
35 
fever diagnosed by rectal temperature, the threshold of infrared 
tympanic thermometry should be 37.4°C to 37.8°C.
27
 Under these 
circumstances, in this systematic review, in one study using rectal 
temperature, mothers on a daily basis verified temperature and threshold 
point was not informed. Fever was associated with teething and the 
mean daily temperature in days of non-eruption was between 36.90ºC 
and 37.10ºC, and in the eruption day 37.60ºC.
11
 Two studies with 
moderate risk of bias used rectal temperatures above 37.77ºC (100ºF)
42
 
and above 37.50ºC;
39
 these authors stated that fever was associated to 
tooth eruption, but mean daily temperature was not informed. Analyzing 
the three most robust studies, one used rectal temperature and detected 
that eruption did not interfere in body temperature with mean daily 
temperature in non-infected children (37.0ºC in non-eruption days and 
36.9ºC in eruption days) in twice daily examinations.
35
 The others used 
tympanic measurements. One study discovered a slight rise from 
36.39ºC in non-eruption days to 36.51ºC in eruption days in a daily 
check by dentists,
33
 while the other one stated that children do not have 
fever in teething period, with 36.18ºC in non-eruption days and 36.21ºC 
in eruption days every weekday by the dental therapist.
10 
 
Limitations 
Some methodological limitations of this review should be 
considered. Different general symptoms were considered among studies 
and not all studies related confounding factors, like other disease that 
might have occurred with tooth eruption, or several symptoms 
happening at the same time. All of these may obscure the actual 
findings.  
Most studies failed in expose a clear definition of the diagnostics 
methods. Examinations were performed in long intervals that could 
compromise adequate data collection. Besides, some symptoms did not 
use objectives measures, but parents’ observation, like irritability and 
loss of appetite. In addition, some symptoms need more specific exam, 
like diarrhea that may be caused by infection and, without a virology 
study the diagnostic is not conclusive.  
Most of the selected studies demonstrated high risk of bias 
especially with relation to study design. Articles with lower risk of bias 
had small samples - 21 to 126 children evaluated. The longest samples 
were found in studies with high risk of bias, although a random effect 
for meta-analysis was used, this might be affected the results. 
Conclusions 
36 
There is evidence of the occurrence of signs and symptoms 
during primary tooth eruption. Gingival inflammation, irritability and 
drooling were the most common. For body temperature analyses, it was 
possible to evaluate that during the eruption of primary teeth there was a 
rise in temperature, but it was not characterized as fever.  
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FIGURE1. Flow diagram of literature search and selection criteria.
1 
1
Adapted from PRISMA 
41 
Study Sample size Proportion (%) 95% CI  
 
    
Carpenter, 1978 120 61,667 52,350 to 70,393 
Cunha, et al, 2004 1165 94,764 93,325 to 95,971 
Jaber et al, 1992 46 43,478 28,934 to 58,893 
King et al, 1999 20 40,000 19,119 to 63,946 
Kiran et al, 2011 894 95,749 94,212 to 96,975 
Noor-Mohammed et al, 
2012 
1100 68,000 65,152 to 70,751 
Peretz et al, 2003 145 60,690 52,243 to 68,690 
Shapira et al, 2003 16 75,000 47,623 to 92,734 
    
Total (fixed effects) 3506 85,616 84,412 to 86,761 
Total (random effects) 3506 70,591 54,198 to 84,622 
Test for heterogeneity  
Q 578,7393 
DF 7 
Significance level P < 0,0001 
I
2
 (inconsistency) 98,79 % 
95% CI for I
2
 98,39 to 99,09 
FIGURE 2. Forest plot for all signs and symptoms that occurred during the eruption of primary teeth. Sample = 3,506. 
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0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Carpenter, 1978
Cunha, et al, 2004
Jaber et al, 1992
King et al, 1999
Kiran et al, 2011
Noor-Mohammed et al, 2012
Peretz et al, 2003
Shapira et al, 2003
Total (fixed effects)
Total (random effects)
42 
 
FIGURE 3. Pooled prevalence for each individual sign or symptom that occurred during the eruption of primary teeth. 
-20
0
20
40
60
80
100
P
o
o
le
d
 P
re
v
a
le
n
c
e
 
Teething Signs and Symptoms 
43 
TABLE1. Summary of descriptive characteristics of included articles (n=16). 
STUDY  POPULATION  INTERVENTION  OUTCOME  
Author, 
Year, 
Countrya 
Study 
design 
Setting Total n Age Mean 
or 
Range 
(Months) 
Clinical 
Assessment 
Body Temperature 
ºC (Who/How) 
Questionnaire Assessed 
Teeth 
Symptoms Follow-Up 
Period 
MTNED/ 
MTED 
(ºC) 
Main Conclusion 
Bengtson et 
al 
1988 
Brazil31 
PS Institutionalized 
children living 
in a shelter 
36 5 - 11 Children were 
examined for 
admission to 
the research. 
Examiner NI 
Nurses/Daily. Type 
of thermometer, 
measurement NI 
 
Nurse daily 
registered 
salivation, 
diarrhea, sleeping 
trouble, irritability, 
runny nose, rash, 
fever, decreased 
appetite, vomiting, 
strong urine, 
itching hearing, 
physical difficulty 
72  88.88% had 
salivation, 87.50% 
diarrhea, 72.22% 
sleeping trouble, 
69.44% irritability, 
68.05% runny nose, 
61.11% rash, 
58.33% fever, 
50.00% decreased 
appetite, 11.40% no 
symptoms 
 
4 months NI/NI Children had 
their teeth 
erupted with 
symptoms 
Carpenter 
1978, 
United 
States42 
RS Well-baby 
clinic of a 
medical 
university 
hospital (South 
Carolina) 
120 records 
 
4 - 10 
 
Medical student 
and a board 
certified 
pediatrician. 
Records 
utilized in the 
study indicated 
teeth were 
erupting that 
time or in 
previous visit 
one month 
before 
 
Medical student and 
a board certified 
pediatrician/ 
Monthly 
Rectal temperatures 
of less than 37.77a 
were not recorded 
as fever 
N Number of 
teeth NI. 
Inferior 
primary 
central 
incisors 
 
39.16% had one 
disturbance and 
22.50% had two or 
more disturbances 
(fever, vomiting, 
diarrhea, drooling, 
irritability, facial 
rash and 
rhinorrhea) 
concurrent with 
teething; 17 
patients had fever  
 
NI NI/ NI There is a 
correlation 
between teething 
process and the 
occurrence of 
systemic 
disturbances 
 
Chakraborty 
et al 
1994, 
India36 
PS Pediatric 
departments of 
different 
hospitals of 
Calcutta and 
pedodontic 
department Dr. 
R. Ahmed 
Dental College 
201 6 - 12 Dentist/2 
months interval 
 
NA Parents were asked 
direct questions on 
the appointment 
day on extend and 
nature of local 
disturbances 
(inflammation of 
the gum, non 
specific oral 
ulcers, cheek flush, 
cheek rash, 
eruption cyst), 
within 2 months 
period 
NI 80.08% suffered 
from at least one 
complication in 
relation to anterior 
teeth and 92.53% 
from posterior 
teeth. Inflammation 
of the gum was the 
most common 
complication 
NI NA Eruption of 
anterior teeth 
was associated 
with less number 
of complications 
than posterior 
teeth 
44 
 
Cunha, et al 
2004, 
Brazil32 
RS Baby clinic of 
Araçatuba 
dental School 
1165 
records 
0 -36 Examiner NI/ 
2 months 
intervals 
Parents were asked 
regarding the 
occurrence of fever, 
Type of 
thermometer, 
measurement NI  
Parents were asked 
regarding the 
occurrence of 
disturbances 
during eruption. 
Gingival irritation, 
runny nose, 
diarrhea, fever, 
general agitation, 
increased 
salivation, agitated 
sleep, was 
analyzed 
889b 95% of the records 
reported some type 
of manifestation, 
85% gingival 
irritation, 74% 
agitation, 70% 
increased 
salivation, 46% 
fever, 39% agitated 
sleep, 35% 
diarrhea, 26% 
runny nose. The 
most frequent teeth 
involved were the 
lower central 
incisors 52%, 
maxillary central 
incisors 20% 
 
Records 
from Jan 
1996 to 
Dec 2001 
were 
analyzed 
NI/NI Children showed 
some type of 
disturbance 
during eruption 
of teeth 
Galili et al. 
1969, 
Israel39 
PS Institutionalized 
children 
residents of a 
Wizo Baby 
Home, 
Jerusalem 
43 5 -23 
Mean 11.07 
(± 0.8) 
Author/Weekly. 
Eruption was 
registered if 
any portion of 
the occlusal 
surface had 
penetrated the 
gingiva 
Nurses/Daily/Rectal 
temperature of at 
least 37.5ºC over a 
period of 2 days 
was designated as 
fever 
Nurses daily 
registered stool, 
consistence and 
number, vomiting, 
sickness, drooling 
and restlessness. 
They referred the 
child to the 
resident 
pediatrician in case 
of any sign of 
disturbance 
93  The difference 
between eruptions 
in periods with 
fever of unknown 
origin and those in 
period of health is 
significant. The 
association 
between eruption 
and fever without 
apparent cause is 
significant. 
Multiple eruptions 
associated with 
fever and illness 
was significant 
4 months NI/ NI There was no 
association 
between tooth 
eruption and 
systemic 
disturbances. 
Eruption and 
fever without 
recognizable 
cause was 
associated.  
Multiple 
eruption and 
disease 
(respiratory and 
alimentary) was 
associated  
 
Hulland et 
al. 
2000, 
Australia30 
PS 3 day-care 
centers 
21 6 - 24 
Mean 14.4 
(± 4.9) 
Dental 
hygienist 
examined 
(tactile and 
visual) the 
alveolar ridges 
to identify 
redness or 
swelling and 
NA NA 128   Only 16 
observation of 
swelling. Redness 
occurred in 85% of 
teeth in the early 
stages of eruption 
7 months NA/ NA During eruption 
most of teeth 
showed signs of 
gingival 
reddening 
(hyperemia) and 
soft tissue 
swelling is 
uncommon 
45 
stage of tooth 
eruption/ Every 
weekday, mid-
morning 
 
Jaber et al. 
1992, 
Israel11 
PS Author’s 
private clinic to 
confirm tooth 
eruption 
46 6 - 18 
 
Mothers 
examined gums 
daily. 
Professional 
confirmation of 
tooth eruption 
Mothers/Daily/ 
Rectal 
Mothers, daily 
noted if there was 
any diarrhea, 
convulsions, 
bronchial 
symptoms, or any 
other diseases; 
medications and 
medical 
examinations. All 
data refer to the 
previous 20 days 
 
Number of 
teeth NI. 
Only data 
collected up 
to the 
eruption of 
the first 
tooth 
(incisors) 
were 
analyzed 
 
Since the day that 
tooth eruption was 
registered was 
referred to day 0, 
and all data refer to 
the previous 20 
days, the results of 
comparison of days 
0 to 9 and 10 to 19 
showed 47 versus 
67 days of otitis 
media, 85 versus 72 
days of diarrhea, 
and 52 versus 58 
days with cough; 
no convulsions 
occurred 
 
NI MTNED 
MDT 36.9 
and 37.1 
from day 19 
to day 4. 
Three days 
before the 
tooth 
eruption 
occurred the 
MDT 
increased to 
37.14 (0.66) 
on day 3, 
37.2 (0.68) 
on day 2, 
37.4 (0.76) 
on day 1. 
 
MTED 
37.6 (0.85) 
on the day 
the tooth 
erupted (95% 
CI 37.33 to 
37.86) 
 
Infants cut their 
teeth with fever 
 
King et al  
1999, 
United 
States43 
CS SG patient at a 
dental school 
pediatric 
dentistry clinic, 
a community 
hospital, and 
the private 
offices of a 
pediatric dentist 
and a 
pediatrician. 
CG selected by 
age-matching to 
SG, at local 
church’s infant 
40 Total 
20 SG 
distress 
from tooth 
eruption 
20 CG no 
distress 
 
7 - 30 
 
Responsible 
personnel at 
each location 
made exam and 
viral sampling 
protocol for 
HVS, for SG 
and one of the 
authors for CG 
subjects. 
Samples for 
viral culture 
were obtained 
from subject’s 
gingiva in both 
Examiner NI/Type 
of thermometer, 
measurement and 
frequency NI. 
When temperatures 
were obtained by 
other than the oral 
method (skin tape, 
rectal), they were 
adjusted to oral 
values for 
comparison 
purposes 
N, only that 
information 
obtained on each 
subject was 
recorded on a 
prepared form and 
included name, 
age, gender, 
temperature, and 
oral findings 
 
NI SG Positive 
cultures for HVS in 
9 infants, they 
presented 
inflammation, 
swelling, vesicles, 
ulceration limited 
to area adjacent/ 
beyond to erupting 
tooth (teeth). CG 
all negative for 
HVS and normal 
oral findings 
 
NA, 
Single 
clinical 
assessment 
MTNED NA 
 
MTED 
SG 7 from 9 
positive for 
HVS had 
temperature 
>37.77a from 
11 negative 5 
presented 
elevated 
temperature 
CG all 
negative for 
HVS normal 
Children had 
elevated 
temperature that 
could not be 
explained by 
other diseases 
during teething 
period 
 
46 
care facility  groups 
 
temperature 
 
Kiran et al  
2011, 
India37 
PS Department of 
Paediatric and 
Preventive 
Dentistry, 
Institute of 
Dental 
Sciences, and 
the Department 
of Paediatrics, 
Rohilkhand 
Medical 
College 
894 6 - 36 
 
Examiner NI/3 
months 
interval. 
Eruption was 
defined as 
visible clinical 
crown of the 
tooth, but not 
exceeding 3 
mm of 
exposure in the 
oral cavity 
Nurse/After dental 
examination. Type 
of thermometer, 
measurement NI 
 
Parents were asked 
about the 
occurrence of local 
and systemic 
disturbances. 
Analysis of the 
records showed the 
presence of the 
following 
symptoms: 
gingival irritations; 
diarrhea; fever; 
loss of appetite; 
irritability; 
increased 
salivation; running 
nose; agitated 
sleep; fever with 
diarrhea; fever 
with increased 
salivation; diarrhea 
with increased 
salivation; fever 
with diarrhea and 
increased 
salivation 
 
Number of 
teeth NI. 
Incisors, 
canines, and 
molars. 
 
95.7% reported 
some type of 
manifestations, 
gingival irritation 
was observed in 
95.9%, irritability 
in 92.1%, fever in 
78.0%. In the 
control group 
92.1% of infants 
did not manifest 
any symptom 
 
11 months  NI/NI Local and 
systemic 
manifestations 
were more 
pronounced 
during eruption 
of primary 
incisors. 
There was 
association 
between primary 
tooth eruption 
and incidence of 
signs and 
symptoms 
Noor-
Mohammed 
et al 
2012, 
India38 
CS Child health 
institute and 
research center 
1100 4 - 36 
 
One of the 
authors. 
Eruption was 
determined if 
the clinical 
crown of the 
tooth was 
visible, but not 
exceeding 3 
mm exposure 
above the 
gingiva  
Mothers complete a 
short and simple 
questionnaire in a 
yes/no manner 
including fever. 
Type of 
thermometer, 
measurement NI. 
Frequency NA 
Parents completed 
a questionnaire in 
a yes/no manner 
about three 
objective 
manifestations 
noted during the 
eruption of the 
primary teeth 
including drooling, 
diarrhea, fever, and 
the combination of 
these symptoms 
Number of 
teeth NI. 
Incisors, 
canines, and 
molars 
 
The most frequent 
clinical 
manifestations 
were: fever (16%), 
drooling (12%), 
diarrhea (8%), 
fever-drooling 
(15%), fever-
diarrhea (8%), 
drooling-diarrhea 
(6%) and the 
combination of 
fever- drooling-
diarrhea 3% 
 
NA, 
Single 
clinical 
assessment 
NI There was 
association 
between general 
objective signs 
(drooling, fever, 
and diarrhea) 
and the eruption 
of primary teeth. 
Most signs 
appeared during 
the eruption of 
the primary 
incisors 
Peretz et al  
2003, 
Colombia34 
CS Public child 
center  
585 
145 SG 
340 CG 
4 - 36 
 
Dentist/ 
Single 
assessment 
Nurse/Frequency 
NA/Type of 
thermometer, 
Parents 
accompanying the 
child completed a 
Number of 
teeth NI. 
Incisors, 
CG 93% of the 
children did not 
present any clinical 
NA, 
Single 
clinical 
NI An association 
has been shown 
between general 
47 
Eruption was 
determined if 
the clinical 
crown of the 
tooth was 
visible, but not 
exceeding 3 
mm exposure 
above the 
gingiva  
measurement NI. 
Fever was recorded 
when exceeded 
39°C. 
 
questionnaire. 
Information was 
relayed in a yes/no 
manner about 3 
objective 
manifestations 
noted during the 
eruption of the 
primary teeth, 
including drooling, 
diarrhea, fever, and 
the combination of 
these symptoms. 
The dentist and the 
nurse confirmed 
drooling and fever 
during the clinical 
check up 
 
canines, and 
molars.  
 
manifestation. In 
the SG, only 39%. 
The most frequent 
clinical 
manifestations 
were: drooling 
(15%), diarrhea 
(13%), and 
drooling-diarrhea 
(8%), fever and 
fever- diarrhea 
(8%) 
 
 
assessment objective signs 
(drooling, fever, 
diarrhea) and the 
eruption of 
primary teeth 
with drooling 
being the most 
prevalent sign. 
Most signs 
appeared during 
the eruption of 
the primary 
incisors 
Ramos-
Jorge et al 
2011, 
Brazil33 
PS/ 
RS 
Residences of 
the infants. 
Non- 
institutionalized 
47 
 
5 - 15 
Mean 8.9  
(± 2.7) 
11 validated 
trained dentists/ 
Daily.  
The day of 
eruption was 
defined as the 
first day on 
which the 
incisor edge 
emerged in the 
oral cavity 
without being 
completely 
covered by 
gingival tissue. 
 
11 validated trained 
dentists/ 
Daily/ 
Infrared auricular 
thermometer and a 
digital axillary 
thermometer. 
Mothers were 
interviewed to 
investigate the 
occurrence of signs 
and symptoms 
such as increased 
salivation, rash, 
runny nose, 
diarrhea, loss of 
appetite, cold, 
irritability, fever, 
smelly urine, 
constipation, 
vomiting, colic, 
and seizure, in the 
previous 24 hours 
and one week after 
the end of data 
collection, the 
mothers answered 
the same 
questionnaire. 
 
23(incisors). 
Mean 
number of 
teeth per 
infant was 
nearly 5 
(range=2-8) 
The associations 
between signs and 
symptoms reported 
by mothers and 
tooth eruption were 
statistically 
significant 
The most common 
symptoms on days 
of eruption were 
irritability, 
increased 
salivation, runny 
nose, and loss of 
appetite. Fever was 
reported five times 
more often in the 
RS 
8 months  MTNED 
Tympanic 
36.39 (0.26) 
Axillary 
35.98 (0.36) 
MTED 
Tympanic 
36.51 (0.20) 
Axillary 
35.99 (0.46) 
There are 
associations 
between teething 
and sleep 
disturbance, 
increased 
salivation, rash, 
runny nose, 
diarrhea, loss of 
appetite, 
irritability, and a 
slight rise in 
temperature. 
Fever was more 
frequently 
reported in the 
RS 
 
Shapira et 
al,  
2003, 
Israel40 
PS Day Care 
Center  
16 5 - 14 
 
Pediatric 
dentist/ Twice 
weekly. 
Eruption of the 
teeth was 
Information 
provided by 
parents/caregivers. 
Twice weekly. 
Type of 
The children’s 
signs and 
symptoms for each 
day were recorded 
by the examining 
50 teeth 
(anterior), 
evaluated 
and samples 
from 21 of 
During the teething 
period, behavioral 
problems were 
observed in 50% of 
the infants, 
5 months  MTNED 
During the 
control 
period, 8% of 
the children 
Teething was 
associated with 
fever, behavioral 
problems, 
coughing, and 
48 
referred to the 
act of teeth 
breaking out 
the gum.  
Fluid from the 
sulcus was 
collected on the 
day of eruption 
or on 1 of the 
following 3 
days. And was 
again collected 
for the control 
group from the 
same tooth 1 
month later 
thermometer, 
measurement NI. 
A child with a 
temperature of 
under 37.5°C was 
classified as having 
“no fever.” A 
temperature of 
37.6°C to 38.5°C 
was regarded as 
low/moderate fever, 
and a temperature 
over 38.5°C was 
classified as high 
fever 
 
dentist on the basis 
of the information 
provided by 
parents as well as 
caregivers at the 
day care center. 
The following 
signs and 
symptoms were 
recorded: fever; 
vomiting; 
gastrointestinal 
disturbances; 
drooling; 
behavioral 
problems; sleep 
disturbances; 
coughing; appetite 
disturbances; and 
biting; sucking  
them for the 
test and the 
control 
group (fluid 
from the 
sulcus) 
compared to 16% 
in the control 
period (P<0.01); 
fever was observed 
in 24% of the 
infants during tooth 
eruption and in 8% 
of the infants 
during the control 
period (P=.04); and 
coughing was 
observed in 12% 
during tooth 
eruption compared 
to 2% (P=.06) of 
the infants during 
the control period. 
In teething period 
vomiting (2%), 
drooling (12%), 
and appetite 
disturbances (12%), 
but were absence 
during the control 
period 
 
exhibited 
low/moderate 
fever, no 
episodes of 
high fever 
were found. 
MDT NI 
 
MTED 
In the 
teething 
period, 14% 
of the 
children 
exhibited 
low/moderate 
fever and 
10% 
exhibited 
high fever 
MDT NI 
the cytokine 
TNFα levels 
 
Tasanen, 
1969, 
Finland35 
PS/CS Nursery, day-
nursery, welfare 
center 
 
SG: PS: 
42 nursery GI 
43 day-nursery 
GII 
41 welfare 
center GIII 
CG: CS: 
107 the same 
locals 
 
126 SG 
107 CG 
+50 
newborn 
and 
50 teething 
children for 
evaluation 
of the gum 
color 
+17 
mucosal 
specimens 
 
 
0 - 30 1 investigator 
with both 
medical and 
dental 
qualifications, 
daily- groups I 
/II and 
summoned 
when eruption 
occurred- group 
III. Eruption: 
first time the 
edge of incisor/ 
cusp of molar 
emerges 
through gingiva 
and is palpable 
with the 
fingernail. 
Coincidental 
infection: if 
Same investigator: 
rectal temperature, 
twice daily 
(morning/ 
afternoon), one-
minute 
thermometer ªC 
Behavior 
disturbances: 
nursing 
staff/mothers. 
Symptoms: sleep, 
daytime restless, 
rubbing the cheek 
and ear, rubbing 
gum and sucking 
the finger, 
drooling, appetite 
and loose stools. 
 
Questionnaire 
maternal opinion: 
200 mother, 100 
more than 40 years 
old. Symptoms: 
fever, sleep 
disturbances, 
restlessness during 
192 
(incisive, 
canine, 
molar).  
Infection during 
eruption: 26% SG, 
15% CG. 
Temperature: NoI 
was in average of 
0.1ªC lower in pre 
and post eruptive 
phase. 
Sedimentation rate: 
during and after 
eruption not 
significant. White 
blood cells during 
eruption: 
significant only for 
lymphocyte ratio in 
SG compared CG. 
Disturbances in 
behavior: statistical 
difference only for 
restless 
Average 
period of 
13.3 days  
MTPE 
NoI 37.0 
I 37.2 
MTED 
NoI 36.9 
I 37.3 
MTP 
NoI 37.0 
I 37.3 
Eruption did not 
influence the 
body 
temperature or 
increase the 
possibility of 
infection. 
Sucking finger, 
rubbing gum, 
drooling, 
daytime 
restlessness, loss 
of appetite 
increased during 
teething. There 
was no change in 
the color of 
mucosa in one 
third of the 
erupting teeth. 
There were some 
49 
fever or other 
signs of 
infection was 
noted one week 
before or 5 days 
after eruption, 
child was place 
in the infected 
group. Blood 
investigation: 
sedimentation 
rate per hour 
and total white 
blood cell 
count. Local 
investigations: 
condition of the 
mucosa: 
normal, slight 
redness and 
deep red. 
Sensitivity of 
gingiva: finger 
palpation, 
moderate 
pressure.  
Sensitivity of 
tooth to 
pressure: with 
special 
equipment 
800g. 
Histological 
investigation: 
gum at the 
eruption site 
 
the day, gum 
rubbing and finger 
sucking, cheek and 
ear rubbing, 
appetite, drooling, 
diarrhea, 
convulsion 
ness and drooling 
in SG and appetite 
showed little 
decrease for SG. 
Local observation: 
gum color chance: 
in 40% was deep 
red. Changes in 
mucosa: 28 in 126 
cases showed slight 
hemorrhages, 
moderate 
pericoronorite, 
fistulas, swelling or 
eruption cyst. No 
difference could be 
found in relation to 
the other findings. 
Pain was not found 
in pressure to the 
gingiva or to the 
erupting teeth. No 
investigation was 
made concerning 
correlation between 
clinical and 
histologic findings. 
At least 20% of 
mothers believed 
their children could 
present some of the 
investigated 
symptoms 
 
local 
complications 
during teething. 
Mother 
attributed some 
disease to 
teething 
Wake et al  
2000, 
Australia10 
PS/ 
RS 
3 child-care 
centers 
21 6 – 24 
Mean 14.4  
(± 4.9) 
Dental therapist 
examined for 
tooth eruption 
every weekday 
(midmorning). 
An eruption 
day was 
defined as the 
first day that 
the edge of an 
Dental therapist 
Every weekday 
(midmorning)/ 
Infrared tympanic 
thermometer  
Two 
questionnaires: to 
staff (afternoon) 
and parents 
(morning) inquired 
about the child’s 
mood, 
wellness/illness, 
drooling/ 
dribbling, sleep, 
90 (incisive, 
canine, 
molar).  
Analysis did not 
indicate a 
relationship 
between tooth 
eruption and fever. 
All parents 
retrospectively 
reported that their 
own child had 
suffered teething 
7 months MTNED 
36.18 
 
MTED 
36.21 
Tooth eruption is 
not associated 
with fever, mood 
disturbance, 
illness, sleep 
disturbance, 
drooling, 
diarrhea, strong 
urine, red 
cheeks, or 
50 
incisor or cusp 
of a molar 
crown could be 
seen or felt 
emerging 
through the 
gum  
 
stools, wet diapers, 
and rashes/flushing 
over the preceding 
24 hours were 
answered every 
weekday. At the 
end of the study, 
parents completed 
a questionnaire 
about their beliefs 
and experiences 
related to teething 
 
symptoms 
 
 
rashes/ flushing 
on the face or 
body  
 
Yam et al, 
2002, 
Senegal41 
PS Child health 
institute Centre 
de Protection 
Maternelle et 
Infantile in 
Dakar-Médina 
499 5 - 30 Medical 
service/ 
Monthly.  
Mothers should 
bring the 
children if there 
were any sign 
or symptoms in 
this period 
Information 
provided by 
parents. 
Type of 
thermometer, 
measurement NI 
 
NI Number of 
teeth NI. 
Incisors, 
canines, and 
molars.  
 
Local observation: 
7 hematoma of 
eruption, 5 
widespread 
gingivitis, 297 local 
gingivitis. At least 
60% of the children 
had one or more of 
the symptoms: 
hyperthermia, 
vomiting, diarrhea 
and appetite 
problems 
NI NI/NI Children cut 
their teeth with 
local and 
systemic 
disturbances 
CG, Control Group; CI, Confidence interval; CS Cross sectional; HSV, herpes simplex virus; I, Infected; MDT, Mean daily temperature; MTED, Mean temperature in eruption days; MTNED, Mean temperature in non-eruption 
days; MTPE, Mean temperature pre-eruption; MTP; Mean temperature post-eruption; NA, Not applicable; NI, Not informed; N, No; NoI, Non-infected; PS, Prospective study; RS, Retrospective study; SD, Standard deviation; SG, 
Study group 
a Data were modified by authors (ºF to ºC) 
b Data calculated by authors 
51 
TABLE 2. Risk of bias summarized assessment (QUIPS
26
).* 
Biases 
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1
9
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3
1
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8
4
2
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1
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4
3
6
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0
4
3
2
 
G
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1
9
6
9
3
9
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2
0
0
0
3
0
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b
er
 e
t 
al
 
1
9
9
2
1
1
 
K
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9
9
9
4
3
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2
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1
1
3
7
 
N
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M
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2
0
1
2
3
8
 
P
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z 
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2
0
0
3
3
4
 
R
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o
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e 
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2
0
1
1
3
3
 
S
h
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a 
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2
0
0
3
4
0
 
T
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 1
9
6
9
3
5
 
W
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e 
et
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l 
2
0
0
0
1
0
 
Y
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, 
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l 
2
0
0
2
4
1
 
Study 
Participation 
 
high mod low low mod low mod low low low low low low low low high 
Study 
Attrition 
 
high x mod x high high high x low low high mod high mod mod high 
PF 
Measurement 
 
high mod high high high mod high high high high low low mod low low high 
Outcome 
Measurement 
 
high low high high low low high high high high mod low low low low high 
Study 
Confounding 
 
high low high high low low high high high high high low low low low high 
Statistical 
Analysis and 
Presentation 
 
high high low high low low high high high low low low low low low high 
Overall high mod high high mod low high high high mod mod low low low low high 
* Abbreviations: QUIPS, Quality in Prognosis Studies Tool; PF, Prognostic factor. Ratings: High, moderate, and low indicates 
high, moderate, and low risk of bias, respectively. 
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TABLE 3. Summarized body temperature assessment. 
Measurement MTNED MTDE Study 
reference 
Association 
Rectal42 NI NI 37.7ºC Yes 
Rectal39 NI NI 37.5ºC Yes 
Rectal11 36.9 – 
37.1ºC 
37.6ºC NI Yes 
Rectal35 37.0ºC 36.9ºC 37.5ºC No 
Tympanic33 36.39ºC 36.51ºC NI Yes (slight rise) 
Tympanic10 36.18ºC 36.21ºC NI No 
NI, Not informed; MTED, Mean temperature in eruption days; MTNED, Mean 
temperature in non-eruption days. 
It was not possible to calculate the weighted average because data was insufficient. 
 
 
 
APPENDIX 1. Search strategy (PubMed). May 6
th
, 2015*. 
Step Search Strategy 
#5 (#1 AND #2 AND #3 AND #4) 
#4 (eruption OR teething) 
#3 (symptom* OR signs OR fever OR “body temperature” OR diarrhoea 
OR diarrhea OR appetite OR “irritable mood” OR irritability OR 
salivation OR sleep OR erythema OR biting OR “runny nose” OR 
“nasal congestion” OR cough OR drooling OR sialorrhea OR “ear 
pulling” OR rash OR vomiting OR “sucking behavior” OR sucking 
OR sign) 
 
#2 ("deciduous tooth" OR deciduous OR "primary dentition" OR 
"primary dentitions" OR "primary teeth" OR "primary tooth" OR 
"milk teeth" OR "milk tooth" OR "baby teeth" OR "baby tooth" OR 
milk-tooth OR "deciduous teeth") 
 
#1 (infant OR baby OR babies OR preschool OR child OR children OR 
infants OR pediatric OR paediatric) 
* This search strategy was adapted for other databases (LILACS, ProQuest 
Dissertations and Theses Database, Scopus and Web of Science). 
Corresponding terms in Portuguese and Spanish were used for LILACS.  
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APPENDIX 2. Excluded articles with reasons for exclusion (n=59). 
Author, Year Reason for Exclusion* 
Abujamrra et al 1994
1
  7 
Abreu-Correa et al 1997
2
  7 
Adimorah et al 2011
3
  7 
Agbaje et al 2012
4
  7 
Andrade et al 1999
5
  7 
Aragão et al 2007
6
  7 
Bankole et al 2004
7
  7 
Bankole et al 2005
8
  7 
Barlow et al 2002
9
  7 
Baykan et al 2004
10
  7 
Bengtson et al 1994
11
 8 
Bennett 1986
12
  7 
Bhavneet et al 2012
13
  7 
Casaretto et al 2007
14
  7 
Coldebella et al 2008
15
  7 
Coreil et al 1995
16
  7 
Crispim et al 1997
17
  7 
Cross et al 2009
18
  7 
De Castro et al 2013
19
  7 
De Rezende et al 2010
20
  7 
Denloye et al 2005
21
  7 
De Rudder et al 1960
22
  2 
Faraco et al 2008
23
  7 
Feldens et al 2010
24
  7 
Freitas et al 2001
25
  7 
Honig et al 1975
26
  7 
Illingworth 1969
27
  2 
Ispas et al 2013
28
  7 
Kakatkar et al 2012
29
  7 
Kasangaki 2004
30
  7 
Macknin et al 2000
31
  7 
Mota-Costa et al 2010
32
  7 
Noronha et al 1985
33
  7 
Olabu et al 2013
34
  5 
Og Uti et al 2005
35
  7 
Owais et al 2010
36
  7 
Oyejide et al 1991
37
  7 
Oziegbe et al 2009
38
  7 
Oziegbe et al 2011
39
  7 
Pierce et al 1986
40
  7 
Plutzer et al 2012
41
  7 
Rocha et al 1988
42
 7 
Ramos-Jorge et al 2013
43
 8 
54 
Sarrell et al 2005
44
  7 
Seward et al 1971
45
  7 
Seward et al 1969
46
  7 
Seward et al 1972
47
  7 
Seward et al 1972
48
  7 
Soliman et al 1978
49
  7 
Sood et al 2010
50
  2 
Steward et al 1988
51
  2 
Swann et al 1979
52
  4 
Szpringer-Nodzak et al 1990
53
  9 
Tighe et al 2007
54
  2 
Vasques 2010
55
  7 
Vogelsberg et al 1972
56
  2 
Wake et al 1999
57
  7 
Wake et al 2002
58
  7 
Wilson et al 2002
59
  2 
* 1 = studies in children aged over 36 months old; 2 = reviews, letters, 
conference abstracts; 3 = studies which the sample included genetic syndromic 
patients; 4 = studies which the sample included malignancies, malnutrition and 
chronic diseases; 5 = studies which the sample included non spontaneous 
eruption of primary teeth; 6 = studies where the eruption of primary teeth was 
not the primary outcome; 7 = studies that clinical exam was not performed by a 
health care professional; 8 = articles that evaluated the same sample; 9 = not 
available. 
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APPENDIX 3. *QUIPS
26
 Risk of Bias Assessment Instrument for Prognostic Factor Studies. 
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1. Study 
Participation 
Goal: To judge the risk of selection bias (likelihood that relationship between PF and outcome is different for participants and 
eligible non-participants). 
Source of target 
population 
The source population or population of 
interest is adequately described for key 
characteristics. 
Y Y Y Y Y Y Y Y 
Method used to 
identify population 
The sampling frame and recruitment are 
adequately described, including methods to 
identify the sample sufficient to limit 
potential bias (number and type used, e.g., 
referral patterns in health care) 
Y Y Y Y Y N Y Y 
Recruitment period 
Period of recruitment is adequately 
described 
Y Y N Y Y Y Y Y 
Place of recruitment 
Place of recruitment (setting and 
geographic location) are adequately 
described 
Y Y Y Y Y Y Y Y 
Inclusion and 
exclusion criteria 
Inclusion and exclusion criteria are 
adequately described (e.g., including 
N Y Y N Y Y Y Y 
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explicit diagnostic criteria or 
 “zero time” description). 
Adequate study 
participation 
There is adequate participation in the study 
by eligible individuals 
N N Y Y N Y N N 
Baseline 
characteristics 
The baseline study sample (i.e., individuals 
entering the study) is adequately described 
for key characteristics. 
N N Y Y N Y N Y 
Summary Study 
participation 
The study sample represents the population 
of interest on key characteristics, sufficient 
to limit potential bias of the observed 
relationship between PF and outcome. 
Rating of "Risk of bias" 
High Mod Low Low Mod Low Mod Low 
2. Study Attrition  
Goal: To judge the risk of attrition bias (likelihood that relationship between PF and outcome are different for completing and non-
completing participants). 
Proportion of 
baseline sample 
available for 
analysis 
Response rate (i.e., proportion of study 
sample completing the study and providing 
outcome data) is adequate. 
N N Y NA NC Y NC NA 
Attempts to collect 
information on 
participants who 
dropped out 
Attempts to collect information on 
participants who dropped out of the study 
are described. 
N NA N NA N N NC NA 
Reasons and 
potential impact of 
subjects lost to 
follow-up 
Reasons for loss to follow-up are provided. N NA Y NA N N NC NA 
Outcome and 
prognostic factor 
information on 
those lost to follow-
up 
Participants lost to follow-up are 
adequately described for key 
characteristics. 
N NA Y NA N Y NC NA 
There are no important differences between 
key characteristics and outcomes in 
participants who completed the study and 
those who did not. 
NC NC NC NC NC Y NC NC 
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Study Attrition 
Summary  
Loss to follow-up (from baseline sample to 
study population analyzed) is not 
associated with key characteristics (i.e., the 
study data adequately represent the sample) 
sufficient to limit potential bias to the 
observed relationship between PF and 
outcome.  
Rating of "Risk of bias" 
High X Mod X High Mod High X 
3. Prognostic Factor 
Measurement 
Goal: To judge the risk of measurement bias related to how PF was measured (differential measurement of PF related to the level of 
outcome). 
 
Definition of the PF 
A clear definition or description of 'PF' is 
provided (e.g., including dose, level, 
duration of exposure, and clear 
specification of the method of 
measurement). 
N N N N Y Y N N 
Valid and Reliable 
Measurement of PF 
Method of PF measurement is adequately 
valid and reliable to limit misclassification 
bias (e.g., may include relevant outside 
sources of information on measurement 
properties, also characteristics, such as 
blind measurement and limited reliance on 
recall). 
N N N N Y N N N 
Continuous variables are reported or 
appropriate cut-points (i.e., not data-
dependent) are used. 
N Y N N Y Y N N 
Method and Setting 
of PF Measurement 
The method and setting of measurement of 
PF is the same for all study participants. 
Y Y Y Y Y Y Y Y 
Proportion of data 
on PF available for 
analysis 
Adequate proportion of the study sample 
has complete data for PF variable. 
N Y Y Y N N N N 
Method used for 
missing data 
Appropriate methods of imputation are 
used for missing 'PF' data. 
NA NA NA NA NA NA NA NA 
PF Measurement PF is adequately measured in study High Mod High High Mod Mod High High 
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Summary  participants to sufficiently limit potential 
bias. 
Rating of "Risk of bias" 
4. Outcome 
Measurement 
Goal: To judge the risk of bias related to 
the measurement of outcome (differential 
measurement of outcome related to the 
baseline level of PF). 
 
Definition of the 
Outcome 
A clear definition of outcome is provided, 
including duration of follow-up and level 
and extent of the outcome construct. 
Y Y Y Y Y Y Y N 
Valid and Reliable 
Measurement of 
Outcome 
The method of outcome measurement used 
is adequately valid and reliable to limit 
misclassification bias (e.g., may include 
relevant outside sources of information on 
measurement properties, also 
characteristics, such as blind measurement 
and confirmation of outcome with valid 
and reliable test). 
N N N N Y Y N N 
Method and Setting 
of Outcome 
Measurement 
The method and setting of outcome 
measurement is the same for all study 
participants. 
N Y Y Y Y Y Y Y 
Outcome 
Measurement 
Summary 
Outcome of interest is adequately measured 
in study participants to sufficiently limit 
potential bias. 
Rating of "Risk of bias" 
High Low High High Low Low High High 
5. Study 
Confounding 
Goal: To judge the risk of bias due to confounding (i.e. the effect of PF is distorted by another factor that is related to PF and 
outcome). 
Important 
Confounders 
Measured 
All important confounders, including 
treatments (key variables in conceptual 
model), are measured. 
N Y N N Y Y N N 
Definition of the 
confounding factor 
Clear definitions of the important 
confounders measured are provided (e.g., 
including dose, level, and duration of 
exposures). 
N Y N N Y Y N N 
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Valid and Reliable 
Measurement of 
Confounders 
Measurement of all important confounders 
is adequately valid and reliable (e.g., may 
include relevant outside sources of 
information on measurement properties, 
also characteristics, such as blind 
measurement and limited reliance on 
recall). 
N Y N N Y Y N N 
Method and Setting 
of Confounding 
Measurement 
The method and setting of confounding 
measurement are the same for all study 
participants. 
NC Y NC Y Y Y NC NC 
Method used for 
missing data 
Appropriate methods are used if imputation 
is used for missing confounder data. 
NA NA NA NA NA NA NA NA 
Appropriate 
Accounting for 
Confounding 
Important potential confounders are 
accounted for in the study design (e.g., 
matching for key variables, stratification, or 
initial assembly of comparable groups). 
N Y N N Y Y N N 
Important potential confounders are 
accounted for in the analysis (i.e., 
appropriate adjustment). 
N Y N N Y Y N N 
Study Confounding 
Summary  
Important potential confounders are 
appropriately accounted for, limiting 
potential bias with respect to the 
relationship between PF and outcome.   
Rating of "Risk of bias" 
High Low High High Low Low High High 
6. Statistical 
Analysis and 
Reporting 
Goal: To judge the risk of bias related to the statistical analysis and presentation of results. 
 
Presentation of 
analytical strategy 
There is sufficient presentation of data to 
assess the adequacy of the analysis. 
N N Y N N  Y N N 
Model development 
strategy 
The strategy for model building (i.e., 
inclusion of variables in the statistical 
model) is appropriate and is based on a 
conceptual framework or model. 
N N Y N Y Y N N 
The selected statistical model is adequate N Y Y N NC Y N Y 
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for the design of the study. 
Reporting of results There is no selective reporting of results. Y N N N Y Y Y Y 
Statistical Analysis 
and Presentation 
Summary 
The statistical analysis is appropriate for 
the design of the study, limiting potential 
for presentation of invalid or spurious 
results. 
Rating of "Risk of bias" 
High High Low High Low Low High High 
Biases 
Issues to consider for judging overall rating 
of "Risk of bias" 
Studies 
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1. Study 
Participation 
Goal: To judge the risk of selection bias (likelihood that relationship between PF and outcome is different for participants and 
eligible non-participants). 
Source of target 
population 
The source population or population of 
interest is adequately described for key 
characteristics. 
Y Y Y Y Y Y Y Y 
Method used to 
identify population 
The sampling frame and recruitment are 
adequately described, including methods to 
identify the sample sufficient to limit 
potential bias (number and type used, e.g., 
referral patterns in health care) 
Y Y Y Y Y Y Y Y 
Recruitment period Period of recruitment is adequately Y Y Y Y Y Y Y N 
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described 
Place of recruitment 
Place of recruitment (setting and 
geographic location) are adequately 
described 
Y Y Y Y Y Y Y Y 
Inclusion and 
exclusion criteria 
Inclusion and exclusion criteria are 
adequately described (e.g., including 
explicit diagnostic criteria or 
 “zero time” description). 
N Y Y Y Y Y Y N 
Adequate study 
participation 
There is adequate participation in the study 
by eligible individuals 
Y Y Y Y Y Y Y N 
Baseline 
characteristics 
The baseline study sample (i.e., individuals 
entering the study) is adequately described 
for key characteristics  
Y Y Y Y Y Y Y N 
Summary Study 
participation 
The study sample represents the population 
of interest on key characteristics, sufficient 
to limit potential bias of the observed 
relationship between PF and outcome. 
Rating of "Risk of bias" 
Low Low Low Low Low Low Low High 
2. Study Attrition     
Goal: To judge the risk of attrition bias (likelihood that relationship between PF and outcome are different for completing and non-
completing participants). 
Proportion of 
baseline sample 
available for 
analysis 
Response rate (i.e., proportion of study 
sample completing the study and providing 
outcome data) is adequate. 
Y Y N Y Y NC Y N 
Attempts to collect 
information on 
participants who 
dropped out 
Attempts to collect information on 
participants who dropped out of the study 
are described. 
Y NA NA N N N N N 
Reasons and 
potential impact of 
subjects lost to 
follow-up 
Reasons for loss to follow-up are provided. Y Y N Y N N N N 
Outcome and 
prognostic factor 
Participants lost to follow-up are 
adequately described for key 
Y Y N Y N N Y N 
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information on 
those lost to follow-
up 
characteristics. 
There are no important differences between 
key characteristics and outcomes in 
participants who completed the study and 
those who did not. 
NC Y N Y Y NC Y N 
Study Attrition 
Summary  
Loss to follow-up (from baseline sample to 
study population analyzed) is not 
associated with key characteristics (i.e., the 
study data adequately represent the sample) 
sufficient to limit potential bias to the 
observed relationship between PF and 
outcome.  
Rating of "Risk of bias" 
Low Low High Mod High High Mod High 
3. Prognostic Factor 
Measurement 
Goal: To judge the risk of measurement bias related to how PF was measured (differential measurement of PF related to the level of 
outcome). 
 
Definition of the PF 
A clear definition or description of 'PF' is 
provided (e.g., including dose, level, 
duration of exposure, and clear 
specification of the method of 
measurement). 
N N Y Y N Y Y N 
Valid and Reliable 
Measurement of PF 
Method of PF measurement is adequately 
valid and reliable to limit misclassification 
bias (e.g., may include relevant outside 
sources of information on measurement 
properties, also characteristics, such as 
blind measurement and limited reliance on 
recall). 
N N N Y N Y Y N 
Continuous variables are reported or 
appropriate cut-points (i.e., not data-
dependent) are used. 
N N Y Y Y Y Y N 
Method and Setting 
of PF Measurement 
The method and setting of measurement of 
PF is the same for all study participants. 
Y Y NC Y Y Y Y Y 
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Proportion of data 
on PF available for 
analysis 
Adequate proportion of the study sample 
has complete data for PF variable. 
Y Y Y Y N Y Y Y 
Method used for 
missing data 
Appropriate methods of imputation are 
used for missing 'PF' data. 
NA NA NA NA NA NA NA NA 
PF Measurement 
Summary  
PF is adequately measured in study 
participants to sufficiently limit potential 
bias. 
Rating of "Risk of bias" 
High High Low Low Mod Low Low High 
4. Outcome 
Measurement 
Goal: To judge the risk of bias related to 
the measurement of outcome (differential 
measurement of outcome related to the 
baseline level of PF). 
 
Definition of the 
Outcome 
A clear definition of outcome is provided, 
including duration of follow-up and level 
and extent of the outcome construct. 
N NA Y Y Y Y Y N 
Valid and Reliable 
Measurement of 
Outcome 
The method of outcome measurement used 
is adequately valid and reliable to limit 
misclassification bias (e.g., may include 
relevant outside sources of information on 
measurement properties, also 
characteristics, such as blind measurement 
and confirmation of outcome with valid 
and reliable test). 
N N N Y Y Y Y N 
Method and Setting 
of Outcome 
Measurement 
The method and setting of outcome 
measurement is the same for all study 
participants. 
N N N Y Y Y Y Y 
Outcome 
Measurement 
Summary 
Outcome of interest is adequately measured 
in study participants to sufficiently limit 
potential bias. 
Rating of "Risk of bias" 
High High Mod Low Low Low Low High 
5. Study 
Confounding 
Goal: To judge the risk of bias due to confounding (i.e. the effect of PF is distorted by another factor that is related to PF and 
outcome). 
Important All important confounders, including Y N N Y Y Y Y N 
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Confounders 
Measured 
treatments (key variables in conceptual 
model), are measured. 
Definition of the 
confounding factor 
Clear definitions of the important 
confounders measured are provided (e.g., 
including dose, level, and duration of 
exposures). 
N N N Y Y Y Y N 
Valid and Reliable 
Measurement of 
Confounders 
Measurement of all important confounders 
is adequately valid and reliable (e.g., may 
include relevant outside sources of 
information on measurement properties, 
also characteristics, such as blind 
measurement and limited reliance on 
recall). 
N N N Y Y Y Y N 
Method and Setting 
of Confounding 
Measurement 
The method and setting of confounding 
measurement are the same for all study 
participants. 
N N N N Y Y Y N 
Method used for 
missing data 
Appropriate methods are used if imputation 
is used for missing confounder data. 
NA NA NA NA NA NA NA NA 
Appropriate 
Accounting for 
Confounding 
Important potential confounders are 
accounted for in the study design (e.g., 
matching for key variables, stratification, or 
initial assembly of comparable groups). 
Y N N Y Y Y Y N 
Important potential confounders are 
accounted for in the analysis (i.e., 
appropriate adjustment). 
N Y Y Y Y Y Y N 
Study Confounding 
Summary  
Important potential confounders are 
appropriately accounted for, limiting 
potential bias with respect to the 
relationship between PF and outcome.   
Rating of "Risk of bias" 
High High High Low Low Low Low High 
6. Statistical 
Analysis and 
Reporting 
Goal: To judge the risk of bias related to the statistical analysis and presentation of results. 
 
Presentation of There is sufficient presentation of data to N Y Y Y Y Y Y N 
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analytical strategy assess the adequacy of the analysis. 
Model development 
strategy 
The strategy for model building (i.e., 
inclusion of variables in the statistical 
model) is appropriate and is based on a 
conceptual framework or model. 
N Y Y Y Y Y Y N 
The selected statistical model is adequate 
for the design of the study. 
N Y Y Y Y Y Y N 
Reporting of results There is no selective reporting of results. Y Y Y Y Y Y Y Y 
Statistical Analysis 
and Presentation 
Summary 
The statistical analysis is appropriate for 
the design of the study, limiting potential 
for presentation of invalid or spurious 
results. 
Rating of "Risk of bias" 
High Low Low Low Low Low Low High 
* Abbreviations: QUIPS, Quality in Prognosis Studies Tool; PF, Prognostic factor. Ratings: High, moderate, and low indicates 
high, moderate, and low risk of bias, respectively. NA, Not Applicable; NC, Not Clear, N, No; Y, Yes. 
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APPENDIX 4. Forest plot of prevalence for each individual sign or 
symptom. A, Forest plot for gingival irritation. Sample = 2059. B, 
Forest plot for irritability. Sample = 2215. C, Forest plot for drooling. 
Sample = 4364. D, Forest plot for loss of appetite. Sample = 1050. E, 
Forest plot for agitated sleep. Sample = 2215. F, Forest plot for runny 
nose. Sample = 2226. G, Forest plot for fever. Sample = 3719. H, Forest 
plot for diarrhea. Sample = 2576 
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APPENDIX 4. Forest plot of revalence for each individual sign or symptom. A, Forest plot for gingival 
irritation. Sample = 2059. B, Forest plot for irritability.  Sample = 2215. C, Forest plot for drooling. Sample 
= 4364. D, Forest plot for loss of appetite. Sample = 1050. E, Forest plot for agitated sleep. Sample = 2215. 
F, Forest plot for runny nose. Sample = 2226. G, Forest plot for fever. Sample = 3719. H, Forest plot for 
diarrhea. Sample = 2576.  
 
A. Gingival I rritation 
 
 
 
Variable for studies Author__Year 
Author, Year 
Variable for total number of cases Total_n 
Total n 
Variable for number of positive cases Gingival_irritation 
Gingival irritation 
 
Study Sample size Proportion (%) 95% CI  
Cunha et al 2004 1165 80,944 78,569 to 83,162 
Kiran et al, 2011 894 91,834 89,842 to 93,545 
Total (fixed effects) 2059 86,106 84,537 to 87,571 
Total (random effects) 2059 86,818 74,464 to 95,516 
 
Test for heterogeneity 
Q 52,7809 
DF 1 
Significance level P < 0,0001 
I
2
 (inconsistency) 98,11 % 
95% CI for I
2
 95,62 to 99,18 
		
	
	
	
	
	
	
Meta-analysis
0,7 0,8 0,9 1,0
Proportion
Cunha et al 2004
Kiran et al, 2011
Total (fixed effects)
Total (random effects)
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B. I rritability 
	
Variable for studies	 Author__Year 
Author, Year	
Variable for total number of cases	 Total_n 
Total n	
Variable for number of positive cases	 Irritability	
	
	
Study	 Sample size	 Proportion (%)	 95% CI 	
Cunha et al 2004 1165 69,700 66,970 to 72,329 
Kiran et al, 2011 894 88,255 85,962 to 90,293 
Ramos-Jorge et al, 2011 47 91,489 79,621 to 97,632 
Tasanen, 1969 109 16,514 10,091 to 24,837 
Total (fixed effects) 2215 76,050 74,218 to 77,813 
Total (random effects) 2215 68,194 44,145 to 87,965 
 
Test for heterogeneity 
Q 302,8950 
DF 3 
Significance level P < 0,0001 
I
2
 (inconsistency) 99,01 % 
95% CI for I
2
 98,52 to 99,34 
	
	
	
	
	
	
	
	
Meta-analysis
0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Cunha et al 2004
Kiran et al, 2011
Ramos-Jorge et al, 2011
Tasanen, 1969
Total (fixed effects)
Total (random effects)
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C. Drooling 
	
Variable for studies Author__Year 
Author, Year 
Variable for total number of cases Total_Sample 
Total Sample 
Variable for number of positive cases Drooling 
	
	
Study	 Sample size	 Proportion (%)	 95% CI 	
Cunha et al 2004 1165 66,352 63,557 to 69,064 
Kiran et al, 2011 894 90,492 88,378 to 92,335 
Noor-Mohammed, 2012 1110 11,892 10,046 to 13,943 
Peretz et al 2003 145 15,172 9,759 to 22,065 
Ramos-Jorge et al, 2011 47 78,723 64,336 to 89,297 
Tasanen, 1969 109 31,193 22,662 to 40,775 
Total (fixed effects) 3470 52,085 50,409 to 53,758 
Total (random effects) 3470 48,789 17,044 to 81,096 
	
Test for heterogeneity 
Q 1868,7453 
DF 5 
Significance level P < 0,0001 
I
2
 (inconsistency) 99,73 % 
95% CI for I
2
 99,67 to 99,78 
	
	
	
	
	
	
	
	
	
Meta-analysis
0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Cunha et al 2004
Kiran et al, 2011
Noor-Mohammed, 2012
Peretz et al 2003
Ramos-Jorge et al, 2011
Tasanen, 1969
Total (fixed effects)
Total (random effects)
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D. Loss of Appetite 
	
	
	
Variable for studies Author__Year 
Author, Year 
Variable for total number of cases Total_n 
Total n 
Variable for number of positive cases Loss_of_appetite 
Loss of appetite 
	
	
Study Sample size Proportion (%) 95% CI  
Kiran et al, 2011 894 37,472 34,289 to 40,738 
Ramos-Jorge et al, 2011 47 59,574 44,266 to 73,631 
Tasanen, 1969 109 18,349 11,583 to 26,906 
Total (fixed effects) 1050 36,314 33,404 to 39,302 
Total (random effects) 1050 37,031 20,560 to 55,231 
	
	
Test for heterogeneity 
Q 28,6221 
DF 2 
Significance level P < 0,0001 
I
2
 (inconsistency) 93,01 % 
95% CI for I
2
 82,92 to 97,14 
	
	
	
	
	
Meta-analysis
0,10,20,30,40,50,60,70,8
Proportion
Kiran et al, 2011
Ramos-Jorge et al, 2011
Tasanen, 1969
Total (fixed effects)
Total (random effects)
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E. Agitated Sleep 
	
	
Variable for studies Author__Year 
Variable for total number of cases Total_n 
Variable for number of positive cases Agitated_sleep 
	
Study Sample size Proportion (%) 95% CI  
Cunha et al 2004 1165 36,652 33,879 to 39,493 
Kiran et al, 2011 894 50,559 47,229 to 53,886 
Ramos-Jorge et al, 2011 47 46,809 32,112 to 61,922 
Tasanen, 1969 109 9,174 4,488 to 16,225 
Total (fixed effects) 2215 40,780 38,727 to 42,859 
Total (random effects) 2215 34,539 21,354 to 49,066 
	
Test for heterogeneity 
Q 106,7486 
DF 3 
Significance level P < 0,0001 
I
2
 (inconsistency) 97,19 % 
95% CI for I
2
 95,05 to 98,40 
	
	
	
	
	
	
	
Meta-analysis
0,00,10,20,30,40,50,60,7
Proportion
Cunha et al 2004
Kiran et al, 2011
Ramos-Jorge et al, 2011
Tasanen, 1969
Total (fixed effects)
Total (random effects)
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F. Runny Nose 
	
	
Variable for studies Author__Year 
Author, Year 
Variable for total number of cases Total_n 
Total n 
Variable for number of positive cases Runny_nose 
Runny nose 
	
Study Sample size Proportion (%) 95% CI  
Carpenter, 1978 120 19,167 12,555 to 27,358 
Cunha et al 2004 1165 24,206 21,771 to 26,772 
Kiran et al, 2011 894 26,174 23,319 to 29,187 
Ramos-Jorge et al, 2011 47 70,213 55,106 to 82,661 
Total (fixed effects) 2226 25,627 23,825 to 27,492 
Total (random effects) 2226 31,321 22,714 to 40,631 
	
	
Test for heterogeneity 
Q 44,3541 
DF 3 
Significance level P < 0,0001 
I
2
 (inconsistency) 93,24 % 
95% CI for I
2
 85,89 to 96,76 
	
	
	
	
	
	
	
	
	
Meta-analysis
0,0 0,2 0,4 0,6 0,8 1,0
Proportion
Carpenter, 1978
Cunha et al 2004
Kiran et al, 2011
Ramos-Jorge et al, 2011
Total (fixed effects)
Total (random effects)
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G. Fever 
	
	
	
Variable for studies Author__Year 
Author, Year 
Variable for total number of cases Total 
Variable for number of positive cases Fever 
	
	 	
	
Study Sample size Proportion (%) 95% CI  
Carpenter, 1978 120 14,167 8,474 to 21,711 
Cunha et al 2004 1165 43,777 40,904 to 46,681 
Jaber et al, 1992 46 43,478 28,934 to 58,893 
Kiran et al, 2011 894 74,720 71,737 to 77,540 
Noor-Mohammed, 2012 1110 15,856 13,755 to 18,140 
Peretz et al 2003 145 7,586 3,848 to 13,168 
Ramos-Jorge et al, 2011 47 17,021 7,647 to 30,809 
Tasanen, 1969 192 10,417 6,480 to 15,629 
Total (fixed effects) 3719 37,081 35,528 to 38,655 
Total (random effects) 3719 26,701 10,545 to 46,995 
	
Test for heterogeneity 
Q 1034,1251 
DF 7 
Significance level P < 0,0001 
I
2
 (inconsistency) 99,32 % 
95% CI for I
2
 99,14 to 99,46 
	
	
	
	
Meta-analysis
0,0 0,2 0,4 0,6 0,8
Proportion
Carpenter, 1978
Cunha et al 2004
Jaber et al, 1992
Kiran et al, 2011
Noor-Mohammed, 2012
 Peretz et al 2003
Ramos-Jorge et al, 2011
Tasanen, 1969
Total (fixed effects)
Total (random effects)
78 
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H. Diarrhea 
	
	
Variable for studies Author__Year 
Author, Year 
Variable for total number of cases Total_n 
Total n 
Variable for number of positive cases Diarrhea 
	
	
Study Sample size Proportion (%) 95% CI  
Cunha et al 2004 1165 32,704 30,014 to 35,482 
Noor-Mohammed, 2012 1110 7,928 6,407 to 9,676 
Peretz et al 2003 145 13,103 8,077 to 19,704 
Ramos-Jorge et al, 2011 47 53,191 38,078 to 67,888 
Tasanen, 1969 109 4,587 1,506 to 10,381 
Total (fixed effects) 2576 18,468 16,988 to 20,020 
Total (random effects) 2576 19,526 6,960 to 36,473 
	
Test for heterogeneity 
Q 288,2248 
DF 4 
Significance level P < 0,0001 
I
2
 (inconsistency) 98,61 % 
95% CI for I
2
 97,95 to 99,06 
	
Meta-analysis
0,00,10,20,30,40,50,60,7
Proportion
Cunha et al 2004
Noor-Mohammed, 2012
Peretz et al 2003
Ramos-Jorge et al, 2011
Tasanen, 1969
Total (fixed effects)
Total (random effects)
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APPENDIX 5. Prevalence of each sign or symptom occurred during the 
eruption of primary teeth. 
Author, Year Total Complication 
Teething Signs and 
Symptoms 
Percentage 
Cunha et al 200432 1165 943 Gingival irritation 80.94 
Kiran et al, 201136 894 821 Gingival irritation 91.83 
   
Mean from Meta-Analysis 86.81 (74.46 to 95.51) 
   
I2 (Inconsistency) 
 
98.11% (95.62 to 99.18) 
Cunha et al 200432 1165 812 Irritability 69.70 
Kiran et al, 201136 894 789 Irritability 88.26 
Ramos-Jorge et al, 
201133 
47 43 Irritability 91.49 
Tasanen, 196934 109 18 Irritability 16.51 
   
Mean from Meta-Analysis 68.19 (44.14 to 87.96) 
   
I2 (Inconsistency) 
 
99.01% (98.52 to 99.34) 
Cunha et al 200432 1165 773 Drooling 66.35 
Kiran et al, 201136 894 809 Drooling 90.49 
Noor-Mohammed, 
201238 
1110 132 Drooling 11.89 
Peretz et al 200334 145 22 Drooling 15.17 
Ramos-Jorge et al, 
201133 
47 37 Drooling 78.72 
Tasanen, 196934 109 34 Drooling 31.19 
   
Mean from Meta-Analysis 48.79 (17,044 to 81,096) 
   
I2 (Inconsistency) 
 
99.73% (99,67 to 99,78) 
Tasanen, 196934 109 45 Sucking finger 
 
41.28 
Kiran et al, 201136 894 335 Loss of appetite 37.47 
Ramos-Jorge et al, 
201133 
47 28 Loss of appetite 59.57 
Tasanen, 196934 109 20 Loss of appetite 18.35 
   
Mean from Meta-Analysis 37.03 (20.56 to 55.23) 
   
I2 (Inconsistency) 
 
93.01% (82.92 to 97.14) 
Cunha et al 200432 1165 427 Agitated sleep 36.65 
Kiran et al, 201136 894 452 Agitated sleep 50.56 
Ramos-Jorge et al, 
201133 
47 22 Agitated sleep 46.81 
Tasanen, 196934 109 10 Agitated sleep 9.17 
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Mean from Meta-Analysis 34.53 (21.35 to 49.06) 
   
I2 (Inconsistency) 
 
97.19 % (95.05 to 98.40) 
Carpenter, 197842 120 23 Runny nose 19.17 
Cunha et al 200432 1165 282 Runny nose 24.21 
Kiran et al, 201136 894 234 Runny nose 26.17 
Ramos-Jorge et al, 
201133 
47 33 Runny nose 70.21 
   
Mean from Meta-Analysis 31.32 (22.71 to 40.63) 
   
I2 (Inconsistency) 
 
93.24% (85.89 to 96.76) 
Carpenter, 197842 120 17 Fever 14.17 
Cunha et al 200432 1165 510 Fever 43.78 
Jaber et al, 199211 46 20 Fever 43.48 
Kiran et al, 201136 894 668 Fever 74.72 
Noor-Mohammed, 
201238 
1110 176 Fever 15.86 
Peretz et al 200334 145 11 Fever 7.59 
Ramos-Jorge et al, 
201133 
47 8 Fever 17.02 
Tasanen, 196934 192 20 Fever 10.42 
   
Mean from Meta-Analysis 26.70 (10.54 to 46.99) 
   
I2 (Inconsistency) 
 
99.32% (99.14 to 99.46) 
Cunha et al 200432 1165 381 Diarrhea 32.70 
Noor-Mohammed, 
201238 
1110 88 Diarrhea 7.93 
Peretz et al 200334 145 19 Diarrhea 13.10 
Ramos-Jorge et al, 
201133 
47 25 Diarrhea 53.19 
Tasanen, 196934 109 5 Diarrhea 4.59 
   
Mean from Meta-Analysis 19.52 (6.96 to 36.47) 
   
I2 (Inconsistency) 
 
98.61% (97.95 to 99.06) 
Carpenter, 197842 120 6 Facial Rash 
 
5.00 
Carpenter, 197842 120 1 Vomiting 0.83 
     
 
  
81 
4 CONSIDERAÇÕES FINAIS 
Os resultados dessa revisão sistemática apontam que podem 
ocorrer  sinais e sintomas durante a erupção dos dentes decíduos, porém 
de menor gravidade como inflamação gengival, irritabilidade e aumento 
de salivação. Febre não esteve relacionada à erupção dos dentes 
decíduos, embora tenha sido observado leve aumento da temperatura 
corporal nos dias de erupção dental. 
Pesquisas com delineamento mais apurado, envolvendo grupo 
controle e determinação dos fatores de confundimento são necessárias. 
Sintomas mais graves, como a diarreia, embora tenham sido relatados 
durante a erupção dos dentes decíduos em alguns estudos, precisam de 
investigação do diagnóstico através de exame por um profissional de 
saúde. 
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pediatras com relação à erupção dentária. Rev. paul. pediatr., São 
Paulo, v. 26, n. 3, p. 258-264, 2008. 
FDA: don't use lidocaine to treat teething pain. J Mich State Dent 
Assoc., n. 96, n. 9, p. 8, 2014. 
FELDENS, C. A. Teething Symptoms in the First Year of Life and 
Associated Factors: A Cohort Study. J Clin Pediatr Dent, v. 34, n. 3, p. 
201-206, 2010. 
GIBBONS, H. L. HEBDON, K. Teething as a Cause of Death A 
Historical Review. West. Med. med. j. west., Los Angeles, v.155, n. 6, 
p. 658-659, Dec. 1991. 
HAYDEN JA, et al. Assessing bias in studies of prognostic factors. Ann 
Intern Med. v. 158, n. 4, p. 280-286, 2013. 
HONIG, P. J. Teething – are today’s pediatricians using yesterday’s 
notions?  J. pediatr., v. 87, n. 3, p. 415-417, Sept. 1975. 
84 
JABER, L.; COHEN, I. J.; MOR, A. Fever associated with teething. 
Arch. dis. child., London, n. 67, p. 233-234, 1992. 
KAKATKAR, G. et al. Parental beliefs about children’s teething in 
Udaipur, India: 
A preliminary study. Braz. oral res., São Paulo, v. 26, n. 2, p. 151-157, 
Mar./Apr. 2012. 
KOZUCH, M., PEACOCK, E., D’AURIA, J. P. Infant Teething 
Information on the World Wide Web: Taking a Byte Out of the Search. 
J. pediatr. health care., St. Loius, v. 29, n.1, p. 38-45, Jan./Feb. 2015. 
MACKNIN, M.L. et al. Symptoms associated with infant teething: a 
prospective study. Pediatr. electron. pages, Elk Grove Village IL, n. 
105, p. 747-752, 2000. 
MCINTYRE, G. T., MCINTYRE, G. M. Teething troubles? British 
Dental Journal, n. 192, p.  251–255, 2002. 
MAIA, L. C., ANTONIO, A. G. Systematic Reviews in Dental 
Research. A Guideline. J. clin. pediatr. dent., Birmingham, v. 37, n. 2, 
p.117-124, 2012 
MARKS, S. C. Jr, SCHROEDER, H. E. Tooth eruption: theories and 
facts. Anat Rec, v. 245, p. 374 - 393, 1996.  
MOHER, D. et al. Preferred reporting items for systematic reviews and 
meta-analyses: The PRISMA statement. Int. j. surg., London, v. 8, n. 5, 
p. 336-341, 2010. 
MOHER, D. et al. Preferred reporting items for systematic review and 
meta-analysis protocols (PRISMA-P) 2015 statement. Systematic 
Reviews., v. 4, n. 1, p. 1- 9, 2015. 
NEEDLEMAN, I.G. A guide to systematic reviews. J. Clin. 
Periodontol.,  Copenhagen, v. 29, suppl. 3, p. 6-9, 2002. 
OLABU, B.O., et al. Impact of Socio-Cultural Practice of Infant/Young 
Child Gum Lancing during Teething. J clin pediatr dent., v. 37, n. 4, p. 
355-359, 2013. 
OWAIS, A. I., ZAWAIDEH, F., BATAINEH, O.  Challenging parents’ 
myths regarding their children’s teething. International Journal of 
Dental Hygiene, n. 8, p. 28–34, 2010. 
 
85 
PROFFIT WR, FRAZIER-BOWERS SA. Mechanism and control of 
tooth eruption: overview and clinical implications.  Orthod Craniofac 
Res., v. 12, p. 59-66, 2009. 
PROSPERO. University of York. Disponível em 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42
015020822. Acessado em Set. 24, 2015 
PLUTZER, K, SPENCER, A. J., KEIRSE, M. J. N. C. How first-time 
mothers perceive and deal with teething symptoms: a randomized 
controlled trial. Child: care, health and development, v. 38, n. 2, p. 
292–299, 2011. 
ROMERO-MAROTO M, SÁEZ-GÓMEZ, J. M. Eruption of Primary 
Dentition - a Grave Health Problem According  to Spanish Doctors  of 
the XVI-XVIII Centuries. J. Dent. Res., v. 88, n. 9, p. 777-80, 2009. 
SARRELL, M. et al. Parent’s and medical personnel’s beliefs about 
infant teething. Patient educ.  couns.,  Limerick, n. 57, p. 122-125, 
2005. 
SEWARD MH. The effectiveness of a teething solution in infants. A 
clinical study. Br dent j., v. 127, n. 10, p. 457-461, 1969. 
SHAPIRA J., et al.Cytokine levels in gingival crevicular fluid of 
erupting primary teeth correlated with systemic disturbances 
accompanying teething. Pediatr Dent., v. 25, n. 5, p. 441-448, 2003. 
SOLIMAN NA, SOLIMAN MM. Clinical, histological and 
histochemical study of the gingiva during eruption. Egypt Dent J., v. 
24, n. 1, p. 1-10, 1978. 
SOOD S, SOOD M. Teething: Myths and facts. J Clin Ped Dent., v. 35, 
n. 1, p. 9-13, 2010. 
STEEDLE JR, PROFFIT WR. The pattern and control of eruptive tooth 
movements. Am J Orthod., v. 87, n. 1, p. 56-66, 1985. 
SWANN, I. L. Teething complications, a persisting misconception. 
Postgrad. med. j., Oxford, n. 55, p. 24-25, Jan. 1979. 
TASANEN A. Eruption of the teeth in children. Suomen 
Hammaslaakariseuran Toimituksia., v. 65, n. 4, p. 217-230, 1969. 
TIGHE, M., ROE, M. F. E.  Does a teething child need serious illness 
excluding? Arch. dis. child.. London, n. 92, p. 266-273, 2007. 
86 
TSANG AKL. Teething, teething pain and teething remedies. 
International Dentistry South Africa., v. 5, n. 4, p. 48-6, 2011. 
ZAKIRULLA, M., ALLAHBAKSH M. Teething trouble and its 
management in children. International Journal Of Dental Clinics., v. 
3, n. 2, p. 75-77, 2011. 
WAKE, M.; HESKETH, K.; ALLEN, M. Parent beliefs about infant 
teething: a survey of Australian parents. J. paediatr. child health, 
Melbourne, n. 35, p. 446-449, 1999. 
WAKE, M.; HESKETH, K.; LUCAS, J. Teething and tooth eruption in 
infants: a cohort study. Pediatr. rev., Elkgrove Village, v. 106, n. 6, p. 
1374-1379, Dec. 2000. 
WAKE, M.; HESKETH, K. Teething symptoms: cross sectional survey 
of five groups of child health professionals. BMJ., London, v. 325, n. 
12, p. 814, Oct. 2002.  
  
87 
APÊNDICES 
APÊNDICE A – ESTRUTURA PERGUNTA PECOS 
A pergunta focada, nesta revisão sistemática foi: Em crianças 
entre 0 e 36 meses, há a ocorrência de sinais e sintomas locais e 
sistêmicos durante a erupção dos dentes decíduos? 
A pergunta focada tem o objetivo de auxiliar os revisores a pensar 
claramente sobre o escopo da revisão. A definição da pergunta focada é 
o primeiro passo da revisão sistemática (NEEDLEMAN, 2002). O 
acrônimo PICO (ou PECO) auxilia a fragmentar a questão em quatro 
partes: Paciente/Problema; Intervenção/Exposição; Comparação e 
Desfecho (MAIA, ANTONIO, 2012). Ainda pode ser acrescentado o 
tipo de estudo, componente S do acrônimo conforme Tabela 1.  
Tabela 1 – Estrutura da pergunta PECO. 
PECOS  
Participantes  (P) Crianças entre 0-36 meses 
Exposição (E) Erupção do dente decíduo  
Comparação (C) Não há 
Outcome ou desfecho (O) Sinais e sintomas locais e sistêmicos 
Tipo de estudo (S) Estudos observacionais  
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APÊNDICE B – CRITÉRIOS DE ELEGIBILIDADE E ESTRATÉGIA 
DE BUSCA COMPLETA 
Nessa revisão foram incluídos estudos observacionais avaliando a 
ocorrência de sinais e sintomas locais e sistêmicos durante a erupção 
espontânea dos dentes decíduos em crianças saudáveis com idade entre 
0 e 36 meses, por meio de exame clínico ou questionário dirigido aos 
pais ou profissionais de saúde. Os sinais e sintomas locais e sistêmicos 
avaliados foram os relatados como relacionados com a erupção dos 
dentes decíduos descritos nos estudos (por exemplo, diminuição do 
apetite, diarreia, aumento da salivação, febre, inflamação, ulceração 
gengival, irritabilidade, erupções cutâneas, rinorreia, perturbações do 
sono, vômitos). 
Os critérios de exclusão foram aplicados nas duas fases de 
seleção dos artigos. Na primeira fase, de leitura de títulos e resumos, 
foram considerados os seguintes critérios de exclusão: 
1 - Estudos realizados em crianças com idade superior a 36 
meses;  
2 - Revisões, cartas, resumos de congressos; 
3 - Estudos em que a amostra incluiu pacientes com síndromes 
genéticas (por exemplo, síndrome de Down, anomalias 
craniofaciais, doenças neuromusculares, etc.);  
4 - Estudos em que a amostra incluiu malignidades, desnutrição e 
doenças crônicas;  
5 - Estudos em que a amostra incluiu erupção não-espontânea dos 
dentes decíduos;  
6 - Estudos em que a erupção dos dentes decíduos não foi o 
desfecho primário.  
Além dos seis critérios citados, na segunda fase, de leitura de texto 
completo, foram adicionados os seguintes critérios de exclusão:  
7 - Estudos em que o exame clínico não foi realizado por um 
profissional de saúde e,  
8 - Artigos que avaliaram a mesma amostra. 
Para identificar os estudos elegíveis, foi realizada busca 
eletrônica nas seguintes bases de dados: Literatura Latino-Americana e 
do Caribe em Ciências da Saúde (LILACS), PubMed, ProQuest 
Dissertations and Theses Database, Scopus e Web of Science. Ainda 
foram adicionadas à busca,  a pesquisa de parte da literatura cinzenta no 
Google Scholar, sendo considerados as primeiras 100 referências 
excluindo-se patentes e citações; e a busca manual nas referências dos 
89 
artigos incluídos para qualquer referência que possa ter sido 
inadvertidamente excluída durante as buscas eletrônicas. Não houve 
limitação quanto ao idioma nem data de publicação dos artigos. A busca 
em todas as bases de dados foi realizada em 6 de maio de 2015. As 
estratégias de busca em cada base de dados está exposta na Tabela 2. A 
sintaxe foi adaptada para cada base de dados. 
Tabela 2 – Estratégia de busca para cada base de dados. Realizada em 6 
de maio de 2015. 
Base de dados  Estratégia de busca 
LILACS   (tw:((decidu* OR "Dente Decíduo" OR "Dentição 
primaria" OR "primeira Dentição" OR "dente de leite" OR 
"dentes de leite" OR "diente primario" OR "dientes 
primarios" OR "primary dentition" OR "primary teeth" OR 
"primary tooth" OR "milk teeth" OR "milk tooth" OR 
"baby teeth" OR "baby tooth") AND (erupção OR erupti* 
OR erupcion OR irrompimento OR irromper OR nascer 
OR nascimento OR "Movimentação Dentária" OR "tooth 
emergence" OR "tooth movement") )) AND (tw:((sintoma* 
OR febre OR "Temperatura Corporal" OR diarreia OR 
apetite OR irrita* OR coriza OR saliva* OR tosse OR 
orelha OR vomit* OR sucção OR mord* OR dor* OR 
symptom* OR "fever" OR "body temperature" OR 
"diarrhoea" OR "diarrhea" OR "appetite" OR "irritable 
mood" OR "nose" OR "nasal congestion" OR "cough" OR 
"sialorrhea" OR "drooling" OR "ear pulling" OR "rash" OR 
"vomiting" OR "pain" OR "sucking"))) AND 
(instance:"regional") AND ( db:("LILACS")) 
 
PubMed (infant OR baby OR babies OR preschool OR child OR 
children OR infants OR pediatric OR paediatric) AND 
("deciduous tooth" OR deciduous OR "primary dentition" 
OR "primary dentitions" OR "primary teeth" OR "primary 
tooth" OR "milk teeth" OR "milk tooth" OR "baby teeth" 
OR "baby tooth" OR milk-tooth OR "deciduous teeth") 
AND (symptom* OR signs OR fever OR “body 
temperature” OR diarrhoea OR diarrhea OR appetite OR 
“irritable mood” OR irritability OR salivation OR sleep OR 
erythema OR biting OR “runny nose” OR “nasal 
congestion” OR cough OR drooling OR sialorrhea OR “ear 
pulling” OR rash OR vomiting OR “sucking behavior” OR 
sucking OR sign) AND (eruption OR teething) 
 
ProQuest (all(("deciduous" OR ("primary" AND "dentition*") OR 
("primary" AND "teeth") OR ("primary" AND "tooth") OR 
("milk" AND "teeth") OR ("milk" AND "tooth") OR 
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("baby" AND "teeth") OR ("baby" AND "tooth")) AND 
(erupt* OR ("tooth" AND "emergence") OR ("tooth" AND 
"movement"))) OR all(teething)) AND all(symptom* OR 
"fever" OR "body temperature" OR "diarrhoea" OR 
"diarrhea" OR "appetite" OR "irritable mood" OR "nose" 
OR "nasal congestion" OR "cough" OR "sialorrhea" OR 
"drooling" OR "ear pulling" OR "rash" OR "vomiting" OR 
"pain" OR "sucking") 
 
Scopus (((TITLE-ABS-KEY("deciduous" OR ("primary" W/5 
"dentition") OR ("primary" W/5 "teeth") OR ("milk" W/5 
"teeth") OR ("baby" W/5 "teeth")) AND TITLE-ABS-
KEY("erupti*" OR ("tooth" W/5 "emergence") OR ("tooth" 
W/5 "movement")))) OR (TITLE-ABS-KEY("teething"))) 
AND (TITLE-ABS-KEY((symptom* OR "fever" OR 
"body temperature" OR "diarrhoea" OR "diarrhea" OR 
"appetite" OR "irritable mood" OR "nose" OR "nasal 
congestion" OR "cough" OR "sialorrhea" OR "drooling" 
OR "ear pulling" OR "rash" OR "vomiting" OR "pain" OR 
"sucking"))) 
 
Web of Science #1 OR #2 = #3 
#3 AND #4 
 
1= (("deciduous" OR ("primary" AND "dentition*") OR 
("primary" AND "teeth") OR ("primary" AND "tooth") OR 
("milk" AND "teeth") OR ("milk" AND "tooth") OR 
("baby" AND "teeth") OR ("baby" AND "tooth")) AND 
(erupti* OR ("tooth" AND "emergence") OR ("tooth" AND 
"movement")))  
2 = ("teething") 
3 = (symptom* OR "fever" OR "body temperature" OR 
"diarrhoea" OR "diarrhea" OR "appetite" OR "irritable 
mood" OR "nose" OR "nasal congestion" OR "cough" OR 
"sialorrhea" OR "drooling" OR "ear pulling" OR "rash" OR 
"vomiting" OR "pain" OR "sucking") 
 
Google Scholar teething signs OR symptoms "eruption of primary teeth" 
 
As referências foram importadas para o programa gerenciador de referências 
EndNote® Basic (Thomson Reuters, New York, EUA) e as duplicadas foram 
eliminadas.  
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APÊNDICE C – EQUIPE DA REVISÃO SISTEMÁTICA E SUAS 
FUNÇÕES 
A triagem dos estudos foi realizada por dois revisores (CM, MB) 
de maneira independente em duas etapas. O processo de avaliação 
começou pela leitura dos títulos e resumos, quando disponíveis, e uma 
etapa posterior de confirmação, pela leitura do manuscrito em forma de 
texto completo. Nos casos em que o resumo não estava disponível, se o 
título fosse sugestivo de inclusão, o artigo foi lido na íntegra para avaliar 
a sua elegibilidade. Caso, depois da leitura do texto completo, ainda 
houvesse quaisquer dúvidas em relação ao estudo, os autores foram 
contatados. 
As discordâncias entre os revisores foram resolvidas por 
consenso. Quando o consenso não foi possível, o terceiro revisor (MC) 
auxiliou na tomada de decisão. A seleção final foi baseada na leitura do 
texto completo. A equipe da revisão sistemática e suas funções 
correspondentes estão dispostas na Tabela 3. 
Tabela 3 - Equipe da revisão sistemática, suas afiliações e funções 
correspondentes. 
Autor Afiliação Contribuições 
1. Carla Massignan UFSC 1R 
2. Michele Bolan UFSC 2R 
3. Mariane Cardoso UFSC 3R 
4. André Luís Porporatti USP E 
5. Secil Aydinoz GATA H.T.H. E 
6. Graziela de Luca Canto COBE UFSC SC 
7. Luis Andre Mendonça Mezzomo COBE UFSC C 
1R = Primeiro Revisor (Conceituação e Desenho do estudo / Busca e seleção / 
Coleta de dados / Análise de dados / Preparação do manuscrito). 2R = Segundo 
Revisor (Conceituação e Desenho do estudo / Busca e seleção / Coleta de dados 
/ Análise de dados / Preparação do manuscrito). 3R = Terceiro Revisor (Análise 
de dados). E = Expert (Conceituação  e Desenho de estudo / Análise de dados). 
SC = Subcoordenador (Conceituação  e Desenho de estudo / Análise de dados). 
C = Coordenador (Conceituação  e Desenho de estudo / Análise de dados).  
Todos os autores: revisão do manuscrito. 
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Os dados foram coletados separadamente por cada um dos dois 
revisores (CM, MB). Qualquer divergência foi resolvida por meio de 
discussão e acordo mútuo entre ambos. Quando o acordo não foi 
possível, o terceiro revisor (MC) auxiliou na decisão final.  
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APÊNDICE D – CRITÉRIOS USADOS PELOS AUTORES PARA 
CLASSIFICAR O RISCO DE VIÉS DOS ARTIGOS 
SELECIONADOS PARA A REVISÃO SISTEMÁTICA SEGUNDO A 
FERRAMENTA DE AVALIAÇÃO DA QUALIDADE QUIPS 
(QUALITY IN PROGNOSIS STUDIES TOOL) 
O risco de viés dos estudos incluídos foi verificado através da 
ferramenta de avaliação da qualidade Quality in Prognosis Studies Tool 
(QUIPS - Avaliação da Qualidade em Estudos de Prognóstico – em 
tradução livre) (HAYDEN, et al., 2013). Dois revisores (CM, MB), de 
forma independente, avaliaram a qualidade dos estudos e o terceiro 
revisor (MC) foi consultado quando não houve consenso. Os critérios 
utilizados para cada um dos seis domínios da ferramenta -  Study 
Participation, Study Attrition, Prognostic Factors Measurement, 
Outcome Measurement, Study Confounding and Statistical Analysis and 
Reporting – para classificar os estudos incluídos como sendo de alto, 
moderado ou baixo risco de viés, estão dispostos na Tabela 4. 
Tabela 4 – Critérios usados pelos autores para classificar o risco de viés 
dos artigos selecionados para a revisão sistemática segundo a ferramenta 
de avaliação da qualidade QUIPS* 
1. Study 
Participation 
Goal: To judge the risk of selection bias (likelihood that 
relationship between PF and outcome is different for 
participants and eligible non-participants). 
Source of 
target 
population 
The source population or 
population of interest is 
adequately described for key 
characteristics. 
- A proveniência dos bebês está 
descrita adequadamente 
Method used 
to identify 
population 
The sampling frame and 
recruitment are adequately 
described, including methods 
to identify the sample sufficient 
to limit potential bias (number 
and type used, e.g., referral 
patterns in health care) 
- Apresenta adequadamente 
número da amostra, idade 
Recruitment 
period 
Period of recruitment is 
adequately described 
- Apresenta adequadamente 
período de seleção da amostra 
Place of 
recruitment 
Place of recruitment (setting 
and geographic location)  are 
adequately described 
- Apresenta adequadamente o 
local/lugar de seleção da 
amostra 
Inclusion and 
exclusion 
criteria 
Inclusion and exclusion criteria 
are adequately described (e.g., 
including explicit diagnostic 
- Apresenta adequadamente os 
critérios de inclusão/exclusão 
como crianças saudáveis, 
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criteria or 
 “zero time” description). 
crianças com doença, crianças 
na época de erupção dos dentes 
decíduos, etc. 
Adequate 
study 
participation 
There is adequate participation 
in the study by eligible 
individuals 
- Apresenta  a abrangência da 
amostra; se é só uma creche, de 
creches de várias partes da 
cidade, mães que trabalham, 
que não trabalham, abrange 
várias classes econômicas 
Baseline 
characteristics 
The baseline study sample (i.e., 
individuals entering the study) 
is adequately described for key 
characteristics. 
- Apresenta adequadamente os 
bebês que entraram na amostra 
final  
Summary 
Study 
participation 
The study sample represents the population of interest on key 
characteristics, sufficient to limit potential bias of the observed 
relationship between PF and outcome. 
Rating of "Risk of bias" 
2. Study 
Attrition  
Goal: To judge the risk of attrition bias (likelihood that 
relationship between PF and outcome are different for 
completing and non-completing participants). 
Proportion of 
baseline 
sample 
available for 
analysis 
Response rate (i.e., proportion 
of study sample completing the 
study and providing outcome 
data) is adequate. 
-A taxa de resposta é adequada 
(considerar maior que 70%) 
Attempts to 
collect 
information 
on 
participants 
who dropped 
out 
Attempts to collect information 
on participants who dropped 
out of the study are described. 
- Apresenta  informação quanto 
à tentativa de rechamada dos 
participantes perdidos   
Reasons and 
potential 
impact of 
subjects lost to 
follow-up 
Reasons for loss to follow-up 
are provided. 
- Razões de perda são descritas 
Outcome and 
prognostic 
factor 
information 
on those lost 
to follow-up 
Participants lost to follow-up 
are adequately described for 
key characteristics . 
- Apresenta  informação quanto 
aos participantes perdidos  
There are no important 
differences between key 
characteristics and outcomes in 
participants who completed the 
study and those who did not. 
- Não há diferença nos 
participantes perdidos e os que 
completaram o estudo 
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Study 
Attrition 
Summary  
Loss to follow-up (from baseline sample to study population 
analyzed) is not associated with key characteristics (i.e., the 
study data adequately represent the sample) sufficient to limit 
potential bias to the observed relationship between PF and 
outcome.  
Rating of "Risk of bias" 
3. Prognostic 
Factor 
Measurement 
Goal: To judge the risk of measurement bias related to how PF 
was measured (differential measurement of PF related to the 
level of outcome).   
Definition of 
the PF 
A clear definition or 
description of 'PF' is provided 
(e.g., including dose, level, 
duration of exposure, and clear 
specification of the method of 
measurement). 
- Apresenta como foi feito o 
diagnóstico da erupção 
dental? Sim(+), não (-) 
Tátil, visual, com iluminação 
(+) não relata (-) 
Dente emergindo através da 
gengiva (++), dente com 3mm 
de coroa exposta (+), não relata 
(-)  
Quem fez o exame: profissional 
de saúde (+), relato de pais (-) 
Quem fez o exame foi o mesmo 
que mediu a temperatura? (-) 
Que fez entrevista? (-) 
- Apresenta como foram 
medidos os sintomas? Sim(+), 
não (-)  
Relato dos pais, exame físico 
(+), medição de temperatura (+) 
- Quando os exames bucal, 
temperatura e relato dos 
sintomas foram feitos? 
Frequência: Diariamente (++), 
mensalmente (+) não relata (-) 
Período: mesmo horário (++), 1 
x/dia (+), >1x/dia (++) 
Tipo de termômetro (+) não 
relata (-) 
Valid and 
Reliable 
Measurement 
of PF 
Method of PF measurement is 
adequately valid and reliable to 
limit misclassification bias 
(e.g., may include relevant 
outside sources of information 
on measurement properties, 
also characteristics, such as 
blind measurement and limited 
reliance on recall). 
- Cita algum cegamento dos 
examinadores 
- Apresenta grupo controle  
- Mãe não sabe qual foi a 
temperatura do bebê antes de 
responder ao questionário 
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Continuous variables are 
reported or appropriate cut-
points (i.e., not data-dependent) 
are used. 
- Apresenta ponto de corte para 
temperatura corporal 
Method and 
Setting of PF 
Measurement 
The method and setting of 
measurement of PF is the same 
for all study participants. 
- O método de medida é o 
mesmo para todos os 
participantes? 
Proportion of 
data on PF 
available for 
analysis 
Adequate proportion of the 
study sample has complete data 
for PF variable. 
- Proporção da amostra é 
adequada para os dados? 
Method used 
for missing 
data 
Appropriate methods of 
imputation are used for missing 
'PF' data. 
- Apresenta métodos de 
imputação de dados 
PF 
Measurement 
Summary  
PF is adequately measured in study participants to sufficiently 
limit potential bias. 
Rating of "Risk of bias" 
4. Outcome 
Measurement 
Goal: To judge the risk of bias related to the measurement of 
outcome (differential measurement of outcome related to the 
baseline level of PF). 
Definition of 
the Outcome 
A clear definition of outcome 
is provided, including duration 
of follow-up and level and 
extent of the outcome 
construct. 
- Apresenta resultado claro, 
incluindo o tempo de 
acompanhamento (nos 
transversais não teremos isto) 
Valid and 
Reliable 
Measurement 
of Outcome 
The method of outcome 
measurement used is 
adequately valid and reliable to 
limit misclassification bias 
(e.g., may include relevant 
outside sources of information 
on measurement properties, 
also characteristics, such as 
blind measurement and 
confirmation of outcome with 
valid and reliable test). 
- Os métodos de medição foram 
adequados 
Method and 
Setting of 
Outcome 
Measurement 
The method and setting of 
outcome measurement is the 
same for all study participants. 
- Métodos de medição 
adequados à todos os 
participantes 
Outcome 
Measurement 
Summary 
Outcome of interest is adequately measured in study 
participants to sufficiently limit potential bias. 
Rating of "Risk of bias" 
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5. Study 
Confounding 
 
Goal: To judge the risk of bias due to confounding (i.e. the 
effect of PF is distorted by another factor that is related to PF 
and outcome). 
Important 
Confounders 
Measured 
All important confounders, 
including treatments (key 
variables in conceptual model), 
are measured. 
-Todos os fatores confundidores 
são medidos como outras 
doenças não relacionadas ao 
dente (as crianças eram 
examinadas por médico ou 
encaminhadas para detecção de 
outra doença?) 
- Os exames foram realizados 
antes, durante e após  a erupção 
dental?  
Definition of 
the 
confounding 
factor 
Clear definitions of the 
important confounders 
measured are provided (e.g., 
including dose, level, and 
duration of exposures). 
- Apresenta definição dos 
fatores confundidores? (outras 
doenças) 
Valid and 
Reliable 
Measurement 
of 
Confounders 
Measurement of all important 
confounders is adequately valid 
and reliable (e.g., may include 
relevant outside sources of 
information on measurement 
properties, also characteristics, 
such as blind measurement and 
limited reliance on recall). 
- Apresenta fatores de 
confundimento plausíveis 
Method and 
Setting of 
Confounding 
Measurement 
The method and setting of 
confounding measurement are 
the same for all study 
participants. 
-Os fatores confundidores são 
aplicáveis em todos os 
participantes?  
Method used 
for missing 
data 
Appropriate methods are used 
if imputation is used for 
missing confounder data. 
- Apresenta métodos de 
imputação de dados 
Appropriate 
Accounting 
for 
Confounding 
Important potential 
confounders are accounted for 
in the study design (e.g., 
matching for key variables, 
stratification, or initial 
assembly of comparable 
groups). 
-Os fatores confundidores são 
levados em consideração no 
delineamento do estudo? 
Important potential 
confounders are accounted for 
in the analysis (i.e., appropriate 
adjustment). 
-Os fatores confundidores são 
levados em consideração na 
análise dos dados? 
Study 
Confounding 
Important potential confounders are appropriately accounted 
for, limiting potential bias with respect to the relationship 
98 
Summary  between PF and outcome. 
Rating of "Risk of bias" 
6. Statistical 
Analysis and 
Reporting 
Goal: To judge the risk of bias related to the statistical analysis 
and presentation of results. 
Presentation 
of analytical 
strategy 
There is sufficient presentation 
of data to assess the adequacy 
of the analysis. 
-Apresenta dados suficientes 
para análise? 
Model 
development 
strategy 
The strategy for model building 
(i.e., inclusion of variables in 
the statistical model) is 
appropriate and is based on a 
conceptual framework or 
model. 
- Estratégia de inclusão das 
variáveis no modelo estatístico 
é apropriada 
The selected statistical model is 
adequate for the design of the 
study. 
- Modelo estatístico é adequado 
para o desenho do estudo? 
Reporting of 
results 
There is no selective reporting 
of results. 
- Apresenta os resultados reais, 
não seletivo 
Statistical 
Analysis and 
Presentation 
Summary 
The statistical analysis is appropriate for the design of the 
study, limiting potential for presentation of invalid or spurious 
results. 
Rating of "Risk of bias" 
* Quality in Prognosis Studies Tool 
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ANEXO  
ANEXO A – REGISTRO PROSPERO 
A fim de aumentar a disponibilidade e acessibilidade dos métodos 
a priori para revisões sistemáticas, reduzir a duplicação de esforços na 
condução das revisões e reduzir o viés de publicação, há um portal on-
line, International Prospective Register of Ongoing Systematic Reviews 
(PROSPERO), que permite registrar a intenção de realizar uma revisão 
sistemática, mesmo antes de ser iniciada (BOOTH, et al., 2011). A 
documentação dos métodos a priori, aumenta a transparência no 
processo de revisão, permitindo que os leitores de revisões sistemáticas 
possam comparar métodos, resultados e análises realizadas com as 
planejadas com antecedência. O registro no PROSPERO permite a 
documentação permanente de 22 itens obrigatórios e 18 opcionais sobre 
o projeto a priori e a condução de uma revisão (MOHER, et al., 2015). 
Assim, o protocolo dessa revisão sistemática foi registrado no 
PROSPERO sob número CRD 42015020822 (PROSPERO, 2015)  
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  Page 1 / 1 
PROSPERO International prospective register of systematic reviews 
Review  t it le  and t im escale  
1 Review title 
Give the working title of the review. This must be in English. Ideally it should state succinctly the interventions or exposures 
being reviewed and the associated health or social problem being addressed in the review. 
Signs and symptoms of eruption of primary teeth: a systematic review and meta-analysis 
2 Original language title 
For reviews in languages other than English, this field should be used to enter the title in the language of the review. This will 
be displayed together with the English language title.  
3 Anticipated or actual start date 
Give the date when the systematic review commenced, or is expected to commence. 
11/02/2015 
4 Anticipated completion date 
Give the date by which the review is expected to be completed. 
01/09/2015 
5 Stage of review at time of this submission 
Indicate the stage of progress of the review by ticking the relevant boxes. Reviews that have progressed beyond the point of 
completing data extraction at the time of initial registration are not eligible for inclusion in PROSPERO. This field should be 
updated when any amendments are made to a published record. 
  The review has not yet started  ×     
      
Review stage Started Completed  
Preliminary searches No Yes 
Piloting of the study selection process Yes No 
Formal screening of search results against eligibility criteria Yes No 
Data extraction No No 
Risk of bias (quality) assessment No No 
Data analysis No No 
 
  Provide any other relevant information about the stage of the review here. 
Review  team  details 
6 Named contact 
The named contact acts as the guarantor for the accuracy of the information presented in the register record. 
Dr Bolan 
7 Named contact email 
Enter the electronic mail address of the named contact. 
michelebolan@hotmail.com 
8 Named contact address 
Enter the full postal address for the named contact.  
Universidade Federal de Santa Catarina UFSC Campus Universitário CCS-ODT-Trindade Florianópolis, Santa Catarina, 
Brasil 88040-900 
9 Named contact phone number 
Enter the telephone number for the named contact, including international dialing code. 
+55483721-9920 
10 Organisational affiliation of the review 
Full title of the organisational affiliations for this review, and website address if available. This field may be completed as 
'None' if the review is not affiliated to any organisation. 
Brazilian Centre for Evidence-based Research, Federal University of Santa Catarina 
Website address: 
http://ufsc.br 
11 Review team members and their organisational affiliations 
Give the title, first name and last name of all members of the team working directly on the review. Give the organisational 
affiliations of each member of the review team. 
  Title First name Last name Affiliation 
Dr Carla Massignan Federal University of Santa Catarina 
Dr Mariane Cardoso Federal University of Santa Catarina 
Dr André Porporatti Bauru School of Dentistry, Bauru, São Paulo, Brazil 
Dr Secil Aydinoz Military Medical Academy Uskudar-Istanbul-Turkey 
Dr Graziela De Luca Canto Brazilian Centre for Evidence-based Research, Federal 
University of Santa Catarina 
Dr Luis Mezzomo Brazilian Centre for Evidence-based Research, Federal 
University of Santa Catarina 
Dr Michele Bolan Federal University of Santa Catarina 
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12 Funding sources/sponsors 
Give details of the individuals, organizations, groups or other legal entities who take responsibility for initiating, managing, 
sponsoring and/or financing the review. Any unique identification numbers assigned to the review by the individuals or 
bodies listed should be included. 
none 
13 Conflicts of interest 
List any conditions that could lead to actual or perceived undue influence on judgements concerning the main topic 
investigated in the review. 
Are there any actual or potential conflicts of interest? 
None known 
14 Collaborators 
Give the name, affiliation and role of any individuals or organisations who are working on the review but who are not listed as 
review team members. 
  Title First name Last name Organisation details 
Ms Maria Gorete Savi Federal University of Santa Catarina 
 
Review  m ethods 
15 Review question(s) 
State the question(s) to be addressed / review objectives. Please complete a separate box for each question. 
In children aged 0 up to 36 months, are there local or systemic signs and symptoms during the eruption of the primary teeth? 
16 Searches 
Give details of the sources to be searched, and any restrictions (e.g. language or publication period). The full search strategy 
is not required, but may be supplied as a link or attachment. 
We will include observational studies related to the spontaneous eruption of primary teeth and the association with local and 
systemic signs and symptoms. Detailed individual search strategies for each of the following bibliographic databases will be 
developed: PubMed, Web of Science, Scopus, Lilacs and ProQuest Dissertations and Theses Database. Hand search of the 
references cited in the selected articles will be also checked. A partial gray literature search will be taken using Google 
Scholar. No restrictions will be placed on the publication date or languages.  
17 URL to search strategy 
If you have one, give the link to your search strategy here. Alternatively you can e-mail this to PROSPERO and we will store 
and link to it. 
 
I give permission for this file to be made publicly available 
Yes 
18 Condition or domain being studied 
Give a short description of the disease, condition or healthcare domain being studied. This could include health and 
wellbeing outcomes. 
Many parents and health professionals believe that there is an association between local and systemic signs and symptoms 
and the eruption of primary teeth. Although it is a part of child development, the association between the eruption of the 
primary teeth and the general health is still controversial. 
19 Participants/population 
Give summary criteria for the participants or populations being studied by the review. The preferred format includes details of 
both inclusion and exclusion criteria. 
Children aged between 0 and 36 months  
20 Intervention(s), exposure(s) 
Give full and clear descriptions of the nature of the interventions or the exposures to be reviewed 
Eruption of primary teeth 
21 Comparator(s)/control 
Where relevant, give details of the alternatives against which the main subject/topic of the review will be compared (e.g. 
another intervention or a non-exposed control group). 
Not applicable. 
22 Types of study to be included initially 
Give details of the study designs to be included in the review. If there are no restrictions on the types of study design eligible 
for inclusion, this should be stated. 
Observational studies 
23 Context 
Give summary details of the setting and other relevant characteristics which help define the inclusion or exclusion criteria. 
Inclusion criteria: Observational studies assessing the occurrence of local and systemic signs and symptoms during the 
spontaneous eruption of primary teeth in healthy children aged between 0 and 36 months, by means of either clinical 
examination or a questionnaire directed to the parents or health care professionals. Exclusion criteria: Phase 1(titles and 
abstracts): 1 - Studies in children aged over 36 months old, 2 - Reviews, letters, conference abstracts, 3 - Studies which the 
sample included genetic syndromic patients (e.g., Down syndrome, craniofacial anomalies, neuromuscular disorders, etc.), 4 
- Studies which the sample included malignancies, malnutrition and chronic diseases, 5 - Studies which the sample included 
non spontaneous eruption of primary teeth, 6 - Studies in which the eruption of primary teeth was not the primary outcome. 
Phase 2 (full-text):the following exclusion criteria were added: 7 - Studies that clinical exam was not performed by a health 
care professional and, 8- Articles that evaluated the same sample. 
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24 Primary outcome(s) 
Give the most important outcomes. 
Local and systemic signs and symptoms associated with the eruption of primary teeth 
Give information on timing and effect measures, as appropriate. 
25 Secondary outcomes 
List any additional outcomes that will be addressed. If there are no secondary outcomes enter None. 
None 
  Give information on timing and effect measures, as appropriate. 
None 
26 Data extraction, (selection and coding) 
Give the procedure for selecting studies for the review and extracting data, including the number of researchers involved and 
how discrepancies will be resolved. List the data to be extracted. 
The selection will be performed in two phases. In phase 1 two reviewers working independently will screen titles and 
abstracts for inclusion in the group of articles for full-text review. If both authors thought that an article should be included or 
excluded then that will be the final decision. If the two authors disagree, the third reviewer will be consulted to help resolve 
the differences. If there are differences remaining, the full article will be assessed. In phase 2, the authors will read the full 
articles to determine which of them finally meet the inclusion criteria. Any additional articles will be included in the review if 
they are recommended by the expert or identified through the citations of relevant articles. These articles need to meet the 
same inclusion criteria as those identified through the search engines. 
27 Risk of bias (quality) assessment 
State whether and how risk of bias will be assessed, how the quality of individual studies will be assessed, and whether and 
how this will influence the planned synthesis. 
The QUIPS (Assessing bias in studies of prognostic factors) tool will be used to judge bias and applicability. 
28 Strategy for data synthesis 
Give the planned general approach to be used, for example whether the data to be used will be aggregate or at the level of 
individual participants, and whether a quantitative or narrative (descriptive) synthesis is planned. Where appropriate a brief 
outline of analytic approach should be given. 
If the data from the studies are relatively homogeneous a meta-analysis will be applied. 
29 Analysis of subgroups or subsets 
Give any planned exploration of subgroups or subsets within the review. ‘None planned’ is a valid response if no subgroup 
analyses are planned. 
None planned 
Review  general inform at ion  
30 Type of review 
Select the type of review from the drop down list. 
Prognostic 
31 Language 
Select the language(s) in which the review is being written and will be made available, from the drop down list. Use the 
control key to select more than one language. 
English 
Will a summary/abstract be made available in English? 
Yes 
32 Country 
Select the country in which the review is being carried out from the drop down list. For multi-national collaborations select all 
the countries involved. Use the control key to select more than one country. 
Brazil 
33 Other registration details 
Give the name of any organisation where the systematic review title or protocol is registered together with any unique 
identification number assigned. If extracted data will be stored and made available through a repository such as the 
Systematic Review Data Repository (SRDR), details and a link should be included here.  
34 Reference and/or URL for published protocol 
Give the citation for the published protocol, if there is one. 
Massignan et al. Signs and symptoms of the eruption of primary teeth: a systematic review and meta-analysis 
Give the link to the published protocol, if there is one. This may be to an external site or to a protocol deposited with CRD in 
pdf format. 
 
I give permission for this file to be made publicly available 
Yes 
35 Dissemination plans 
Give brief details of plans for communicating essential messages from the review to the appropriate audiences. 
Do you intend to publish the review on completion? 
Yes 
36 Keywords 
Give words or phrases that best describe the review. (One word per box, create a new box for each term) 
Review 
Teething 
Tooth eruption 
Signs 
Symptoms 
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Fonte: PROSPERO. University of York. Disponível em 
<http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD4201502
0822> Acessado em: 24, set. 2015. 
  
36 Keywords 
Give words or phrases that best describe the review. (One word per box, create a new box for each term) 
Review 
Teething 
Tooth eruption 
Signs 
Symptoms 
Deciduous tooth 
37 Details of any existing review of the same topic by the same authors 
Give details of earlier versions of the systematic review if an update of an existing review is being registered, including full 
bibliographic reference if possible. 
38 Current review status 
Review status should be updated when the review is completed and when it is published. 
Ongoing 
39 Any additional information 
Provide any further information the review team consider relevant to the registration of the review. 
40 Details of final report/publication(s) 
This field should be left empty until details of the completed review are available.  
Give the full citation for the final report or publication of the systematic review. 
Give the URL where available. 
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ANEXO B – PRISMA CHECKLIST* - LISTA DE VERIFICAÇÃO 
DOS ITENS A SEREM INCLUÍDOS NO REPORTE DE UMA 
REVISÃO SISTEMÁTICA OU META-ANÁLISE. 
Essa revisão sistemática foi conduzida usando o PRISMA checklist 
(MOHER, 2010) 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-
analysis, or both.  
 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as 
applicable: background; objectives; data sources; 
study eligibility criteria, participants, and 
interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and 
implications of key findings; systematic review 
registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the 
context of what is already known.  
 
Objectives  4 Provide an explicit statement of questions being 
addressed with reference to participants, 
interventions, comparisons, outcomes, and study 
design (PICOS).  
 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where 
it can be accessed (e.g., Web address), and, if 
available, provide registration information 
including registration number.  
 
Eligibility 
criteria  
6 Specify study characteristics (e.g., PICOS, length 
of follow-up) and report characteristics (e.g., 
years considered, language, publication status) 
used as criteria for eligibility, giving rationale.  
 
Information 
sources  
7 Describe all information sources (e.g., databases 
with dates of coverage, contact with study 
authors to identify additional studies) in the 
search and date last searched.  
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Search  8 Present full electronic search strategy for at 
least one database, including any limits used, 
such that it could be repeated.  
 
Study selection  9 State the process for selecting studies (i.e., 
screening, eligibility, included in systematic 
review, and, if applicable, included in the meta-
analysis).  
 
Data collection 
process  
10 Describe method of data extraction from reports 
(e.g., piloted forms, independently, in 
duplicate) and any processes for obtaining and 
confirming data from investigators.  
 
Data items  11 List and define all variables for which data 
were sought (e.g., PICOS, funding sources) and 
any assumptions and simplifications made.  
 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of 
bias of individual studies (including 
specification of whether this was done at the 
study or outcome level), and how this 
information is to be used in any data synthesis.  
 
Summary 
measures  
13 State the principal summary measures (e.g., risk 
ratio, difference in means).  
 
Synthesis of 
results  
14 Describe the methods of handling data and 
combining results of studies, if done, including 
measures of consistency (e.g., I2) for each meta-
analysis.  
 
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may 
affect the cumulative evidence (e.g., publication 
bias, selective reporting within studies).  
 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., 
sensitivity or subgroup analyses, meta-
regression), if done, indicating which were pre-
specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for 
eligibility, and included in the review, with 
reasons for exclusions at each stage, ideally 
with a flow diagram.  
 
Study 
characteristics  
18 For each study, present characteristics for 
which data were extracted (e.g., study size, 
PICOS, follow-up period) and provide the 
citations.  
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Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if 
available, any outcome level assessment (see item 
12).  
 
Results of 
individual 
studies  
20 For all outcomes considered (benefits or harms), 
present, for each study: (a) simple summary data 
for each intervention group (b) effect estimates 
and confidence intervals, ideally with a forest 
plot.  
 
Synthesis of 
results  
21 Present results of each meta-analysis done, 
including confidence intervals and measures of 
consistency.  
 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias 
across studies (see Item 15).  
 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., 
sensitivity or subgroup analyses, meta-regression 
[see Item 16]).  
 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the 
strength of evidence for each main outcome; 
consider their relevance to key groups (e.g., 
healthcare providers, users, and policy makers).  
 
Limitations  25 Discuss limitations at study and outcome level 
(e.g., risk of bias), and at review-level (e.g., 
incomplete retrieval of identified research, 
reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in 
the context of other evidence, and implications for 
future research.  
 
FUNDING   
Funding  27 Describe sources of funding for the systematic 
review and other support (e.g., supply of data); 
role of funders for the systematic review. 
 
*Fonte: MOHER D, LIBERATI A, TETZLAFF J, ALTMAN DG, THE 
PRISMA GROUP (2009) Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed.1000097 
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ANEXO C – NORMAS DA REVISTA PEDIATRICS* 
Author Guidelines 
Pediatrics is the official peer-reviewed journal of the American 
Academy of Pediatrics. Pediatrics publishes original research, clinical 
observations, and special feature articles in the field of pediatrics, as 
broadly defined. Contributions pertinent to pediatrics also include 
related fields such as nutrition, surgery, dentistry, public health, child 
health services, human genetics, basic sciences, psychology, psychiatry, 
education, sociology, and nursing. 
Pediatrics considers unsolicited manuscripts in the following categories: 
reports of original research, particularly clinical research; review 
articles; special articles; and case reports. When preparing a manuscript 
for Pediatrics, authors must first determine the manuscript type and then 
prepare the manuscript according to the specific instructions below. 
The electronic edition of Pediatrics is the journal of record. Some 
accepted articles may also be presented in full in the print version. The 
editors reserve the right to determine whether an accepted manuscript 
will be published in the print edition in addition to the electronic edition 
of Pediatrics. 
Acceptance Criteria 
Relevance to readers is of primary importance in manuscript selection. 
The readership includes general and specialist pediatricians, pediatric 
researchers and educators, and child health policy-
makers. Pediatrics receives many more high quality manuscripts than 
can be accommodated based on our available space. The current 
acceptance rate is approximately 10%. An article that is thought by the 
editors to be not relevant to readers, outside of scope or very unlikely to 
be accepted may be rejected without review. All manuscripts considered 
for publication are peer reviewed. Peer reviewers are selected by the 
editors based on their expertise in the topic of the manuscript; generally 
at least 2 reviews are required before a decision is rendered. Authors 
may suggest appropriate reviewers and may also suggest reviewers who 
should not review the manuscript. 
Authors should carefully follow instructions for manuscript preparation, 
and ensure that the manuscript is proofread before submission. 
Manuscripts that do not adhere to the author instructions will not be 
considered for review. Careless preparation of a manuscript suggests 
careless execution of the research and therefore makes acceptance 
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unlikely. Manuscripts are scanned for plagiarism using the latest 
software; if potential plagiarism is detected, the editors will contact the 
authors for clarification, and may also contact the authors’ institution. 
Submissions of original research are judged on the importance and 
originality of the research, scientific strength, clinical relevance, the 
clarity of the manuscript, and the number of submissions on the same 
topic. Pediatrics does not publish manuscripts that involve animal 
research. 
Pediatrics accepts review articles, with preference given to systematic 
reviews, which may include meta-analyses. State-of-the-Art Review 
Articles and Perspectives are generally solicited by the editors or the 
associate editors for their respective sections. Special Articles reflect 
topics or issues of relevance to pediatric health care that do not conform 
to a traditional study format. Case Reports must challenge an existing 
clinical or pathophysiologic paradigm; provide a starting point for novel 
hypothesis-testing clinical research; and/or focus on topics pertinent to 
the pediatric generalist. Quality Reports provide a venue for manuscripts 
that describe the implementation and outcome of quality-improvement 
projects.  Authors should review and follow the comprehensive 
reporting guidelines for a wide variety of study designs that are 
available at http://www.equator-network.org/home/. 
Authors submitting manuscripts involving adverse drug or medical 
device events or product problems should also report these to the 
appropriate governmental agency. 
Unsolicited commentaries will be considered for publication; however, 
most commentaries are solicited by the editors. Responses to a 
published article should be submitted as eLetters (see this section); 
selected eLetters may be published in the journal as Letters to the 
Editor. 
Incorrect grammar, language use, or syntax may distract readers from 
the science being communicated and may lead to less favorable reviews. 
To help reduce this possibility, we strongly encourage authors to have 
their manuscripts reviewed for clarity by colleagues. If the authors’ 
native language is not English, we strongly encourage review and 
editing by a colleague whose native language is English or the use of an 
English language editing service. 
109 
Peer reviewers are asked to assess each manuscript for originality; for 
interest to scientists, practitioners and policy makers; for quality of the 
analysis; and for quality of the presentation, and are asked to assess the 
priority of the paper for publication. After the reviews are received, the 
editors may take one of the following actions: Accept; Accept with 
Revisions; Reject with option to Resubmit; or Reject. A rejected 
manuscript may not be resubmitted. A manuscript may be rejected with 
an option to resubmit when additional data or analyses are requested by 
reviewers, or when extensive revision of the text is needed. The 
resubmitted manuscript receives an additional round of peer review 
(which may include new reviewers), and the manuscript may or may not 
be accepted. A decision of Accept with Revision indicates that the 
editors intend to accept the manuscript contingent on adequate response 
to reviewers. A decision of Accept(which is exceedingly rare on first 
submission) indicates that the manuscript is ready to place into 
production without further modification. Decisions by the editors are 
final. 
Publication Ethics 
Authorship. An “author” is someone who has made substantive 
intellectual contributions to a published study. Each author is required to 
meet ALL FOUR of the following criteria: 
1. Substantial contribution(s) to conception and design, acquisition 
of data, or analysis and interpretation of data; AND 
2. Drafting the article or revising it critically for important 
intellectual content; AND 
3. Final approval of the version to be published, AND 
4. Agreement to be accountable for all aspects of the work in 
ensuring that questions related to the accuracy or integrity of any 
part of the work are appropriately investigated and resolved. 
NOTE: Acquisition of funding, collection of data, or general supervision 
of the research group alone does not constitute a sufficient basis for 
authorship. 
All persons listed as authors must meet these criteria, and all persons 
who meet these criteria must be listed as authors. 
Although Pediatrics does not specifically limit the number of authors 
(except for Case Reports), articles submitted with an unusual number of 
authors invite scrutiny by editors and reviewers for clear justification for 
the presence of each person on the authorship list. Pediatrics does not 
permit more than one author to claim any particular position in the 
author list (e.g., two first authors, or two senior authors). 
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Decide authorship issues, including the order, before submission. Except 
in instances where the editorial office has determined that a person does 
not qualify for authorship, Pediatrics does not allow changes to the 
author order, including adding or removing authors from a paper or any 
subsequent revisions. 
 
Conflict of Interest and Disclosure. After a paper is accepted 
by Pediatrics for publication, all authors must submit conflict of interest 
and disclosure forms. Pediatrics adheres to the policy and uses the 
standardized disclosure form of the International Committee of Medical 
Journal Editors (ICMJE). The collection of the forms is automated 
within the online system. 
 
IRB Approval. All studies that involve human subjects must be 
approved or deemed exempt by an official institutional review board; 
this should be noted in the Methods section of the manuscript. 
 
Industry Sponsorship. Pediatrics generally does not accept reports of 
studies in which all authors are employed by a commercial entity with a 
financial interest in the results of the study. 
 
Registration of Clinical Trials. All clinical trials must be registered in 
a World Health organization-approved Clinical Trial registry prior to 
enrollment of the first subject. The registry name and registration 
number should be included on the title page. Reports of unregistered 
trials will be returned to authors without review. Publication of the 
results of a trial that was initiated prior to the ICMJE requirement for 
trial registration will be considered by the editors on a case-by-case 
basis. 
 
Journal Style 
All aspects of the manuscript, including the formatting of tables, 
illustrations, and references and grammar, punctuation, usage, and 
scientific writing style, should be prepared according to the most 
current AMA Manual of Style(http://www.amamanualofstyle.com).
1 
 
Author Listing. All authors’ names should be listed in their entirety, 
and should include institutional/professional affiliations and degrees 
held. 
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Authoring Groups. If you choose to include an organization, 
committee, team, or any other group as part of your author list, you must 
include the names of the individuals as part of the Acknowledgments 
section of your manuscript. This section should appear after the main 
text prior to your References section. The terms “for” or “on behalf of” 
must also be used when referencing the authoring group in the by-line. 
 
Titles.  Pediatrics generally follows the guidelines of the AMA Manual 
of Style for titles. Titles should be concise and informative, containing 
the key topics of the work. Declarative sentences are discouraged as 
they tend to overemphasize a conclusion, as are questions, which are 
more appropriate for editorials and commentaries. Subtitles, if used, 
should expand on the title; however, the title should be able to stand on 
its own. It is appropriate to include the study design (“Randomized 
Controlled Trial”; “Prospective Cohort Study”, etc.) in subtitles. The 
location of a study should be included only when the results are unique 
to that location and not generalizable. Abbreviations and acronyms 
should be avoided. The full title will appear on the article, the inside 
table of contents, and in MEDLINE. Full titles are limited to 97 
characters, including spaces. Short titles must be provided as well and 
are limited to 55 characters, including spaces. Short titles may appear on 
the cover of the journal as space permits in any given issue. 
Abbreviations. List and define abbreviations on the Title Page. Unusual 
abbreviations should be avoided. All terms to be abbreviated in the text 
should also be spelled out at first mention, followed by the abbreviation 
in parentheses. The abbreviation may appear in the text thereafter. 
Abbreviations may be used in the abstract if they occur 3 or more times 
in the abstract. Abbreviations should be avoided in tables and figures; if 
used they should be redefined in footnotes. 
 
Units of Measure. Like many US-based journals, Pediatrics uses a 
combination of Système International (SI)
2,3
 and conventional units. 
Please see the AMA Manual of Style for details. 
Proprietary Products. Authors should use nonproprietary names of 
drugs or devices unless mention of a trade name is pertinent to the 
discussion. If a proprietary product is cited, the name and location of the 
manufacturer must also be included. 
 
References. Authors are responsible for the accuracy of references. 
Citations should be numbered in the order in which they appear in the 
text. Reference style should follow that of the AMA Manual of Style, 
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current edition. Abbreviated journal names should reflect the style of 
Index Medicus. Visit: http://www.nlm.nih.gov/tsd/serials/lji.html 
 
Reuse of Data Sets 
If a manuscript uses the same or similar data contained in previously 
published articles, the authors must state this in the initial letter of 
submission and provide citations to the related or possibly duplicative 
materials. 
Formatting Requirements 
All submissions must adhere to the following format: 
 Times New Roman font, size 12, black 
 Title Page, Contributors' Statement Page, Abstract, 
Acknowledgments, 
and References should be single-spaced 
 Only the Main Body Text should be double-spaced 
 Main Submission Document as Microsoft Word or RTF file (no 
PDFs) 
 Do not include page headers, footers, or line numbers in new 
submissions. 
 Do not include footnotes within the manuscript body. Footnotes 
are allowed only in tables/figures. 
Refer to the “Article Types” section for specific guidelines on preparing 
a manuscript in each category. Note in particular the requirements 
regarding abstracts for different categories of article. 
Title Page 
The “title page” should appear first in your manuscript document, and 
depending on the individual needs of a paper may encompass more than 
one page. 
Title pages for all submissions must include the following items (as 
shown in the sample Title Page): 
1. Title (97 characters [including spaces] or fewer) 
2. Author listing. Full names for all authors, including degrees, and 
institutional/professional affiliations. 
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3. Corresponding Author. Contact information for the 
Corresponding Author (including: name, address, telephone, and 
e-mail). 
4. Short title (55 characters [including spaces] or fewer). Please 
note: the short title may be used on the cover of the print edition. 
5. Financial Disclosure Statement for all authors. Disclose any 
financial relationships that could be broadly relevant to the work. 
If none, say “Financial Disclosure: The authors have no financial 
relationships relevant to this article to disclose.” 
6. Funding source. Research or project support, including internal 
funding, should be listed here; if the project was done with no 
specific support, please note that here. Technical and other 
assistance should be identified in Acknowledgments. If your 
funding body has open access requirements, please contact the 
Editorial Office prior to submission. Pediatrics has a 12 month 
embargo on articles (followed by a 4 year open access period) 
and does not allow articles to be opened for Creative Commons 
or similar licenses. 
7. Conflict of Interest Statement for all authors. If none, say 
“Potential Conflicts of Interest: The authors have no conflicts of 
interest relevant to this article to disclose.” 
8. If applicable, Clinical Trial registry name and registration 
number. We adhere to ICMJE guidelines which require that all 
trials must be registered with ClinicalTrials.gov or any other 
WHO Primary registry. 
9. Abbreviations. List and define abbreviations used in the text. If 
none, say "Abbreviations: none". 
10. For Regular Article submissions, include the “What’s Known on 
This Subject; What This Study Adds” (see below under article 
type for description). This is not needed for any other article type. 
 
Contributors' Statement Page 
All submissions must contain a Contributors’ Statement Page, 
directly following the Title Page. Manuscripts lacking this page will 
be returned to the authors for correction. 
All persons designated as authors should qualify for authorship (see 
"Publication Ethics" above), and all those who qualify should be listed. 
Each author should have participated sufficiently in the work to take 
public responsibility for appropriate portions of the content. The 
Contributors' Statement Page should list the authors in order, and for 
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each, specify the contribution(s) made by that individual. Follow the 
required format shown in this example when creating your 
Contributors’ Statement Page: 
 
Contributors' Statement: 
Dr Smith conceptualized and designed the study, drafted the 
initial manuscript, and approved the final manuscript as 
submitted. 
Drs Jones, Smithee, and Weber carried out the initial analyses, 
reviewed and revised the manuscript, and approved the final 
manuscript as submitted. 
Ms Green designed the data collection instruments, and 
coordinated and supervised data collection at two of the four 
sites, critically reviewed the manuscript, and approved the final 
manuscript as submitted. 
Note: Contributors who do not meet the criteria for authorship (such as 
persons who helped recruit patients for the study, or professional 
editors) should be listed in an Acknowledgments section placed after the 
manuscript’s conclusion and before the References section. Because 
readers may infer their endorsement of the data and conclusions, these 
persons must give written permission to be acknowledged. These 
permissions do not need to be submitted with the manuscript unless 
requested by the editors. 
 
Word Count 
To determine article length, count the body of the manuscript (from the 
start of the Introduction to the end of the Conclusion). The title page, 
contributors' statement page, abstract, acknowledgments, references, 
figures, tables, and multimedia are not included. 
Figures, Tables, and Supplementary Material 
Figures 
Authors should number figures in the order in which they appear in the 
text. Figures include graphs, charts, photographs, and illustrations. Each 
figure should be accompanied by a legend that does not exceed 50 
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words. Abbreviations previously expanded in the text are acceptable. If 
a figure is reproduced from another source, authors are required to 
obtain permission from the copyright holder, and proof of permission 
must be uploaded at the time of submission. 
Figure arrays should be clearly labeled, preassembled, and submitted to 
scale. Figure parts of an array (A, B, C, etc.) should be clearly marked in 
capital letters in the upper left-hand corner of each figure part. 
Technical requirements for figures: The following file types are 
acceptable: TIFF, PDF, EPS, and PNG. Color files must be in CMYK 
(cyan, magenta, yellow, black) mode. 
 
Style for figures:  Readers should be able to understand figures without 
referring to the text. Avoid pie charts, 3-dimensional graphs, and excess 
ink in general. Make sure that the axes on graphs are labeled, including 
units of measurement, and that the font is large enough to read. 
Generally delete legends or other material from the graph if it makes the 
picture smaller. Color graphs should be interpretable if photocopied in 
black and white. 
Please note: A charge will be billed for each color figure appearing in 
the print edition. You will have the opportunity to decline the use of 
color and have your figure converted to black and white during your 
review of page proofs. 
 
Pediatrics cannot accept Excel or PowerPoint files for any part of 
your submission. 
 
Tables 
Tables should be numbered in the order in which they are cited in the 
text and include appropriate headers. Tables should not reiterate 
information presented in the Results section, but rather should provide 
clear and concise data that further illustrate the main point. Tabular data 
should directly relate to the hypothesis. Table formatting should follow 
the current edition of the AMA Manual of Style. 
Style for tables:  Tables should be self-explanatory. Avoid 
abbreviations; define any abbreviations in footnotes to the table. Avoid 
excess digits and excess ink in general. Where possible, rows should be 
in a meaningful order (e.g., descending order of frequency). Provide 
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units of measurement for all numbers. In general, only one type of data 
should be in each column of the table. 
 
Presentation of Numbers and Statistics 
 Results in the abstract and the paper generally should include 
estimates of effect size and 95% confidence intervals, not just P- 
values or statements that a difference was statistically significant. 
 Statistical methods for obtaining all P-values should be provided 
 Units of independent variables must be provided in tables and 
results sections if regression coefficients are provided 
 Authors should avoid expressing effect sizes in the form of highly 
derived statistics. 
 
Supplemental Information 
Authors may wish to include additional information as part of their 
article for inclusion in the online edition ofPediatrics. References to any 
online supplemental information must appear in the main article. Such 
supplemental information can include but are not limited to additional 
tables, figures, videos, audio files, slide shows, data sets (including 
qualitative data), and online appendices. If your study is based on a 
survey, consider submitting your survey instrument or the key questions 
as a data supplement. Authors are responsible for clearly labeling 
supplemental information and are accountable for its accuracy. 
Supplemental information will be peer reviewed, but not professionally 
copyedited. 
 
Videos 
Pediatrics encourages the submission of videos to accompany articles 
where relevant. Links can be placed in the article for use when it is 
accessed electronically. All videos must adhere to the same general 
permission rules that apply to figures (i.e.: parental consent when a 
patient is identifiable). 
All videos should be submitted at the desired reproduction size and 
length. To avoid excessive delays in downloading the files, videos 
should be no more than 6MB in size, and run between 30 and 60 
seconds in length. In addition, cropping frames and image sizes can 
significantly reduce file sizes. Files submitted can be looped to play 
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more than once, provided file size does not become excessive. Video 
format must be either .mov or .mp4. 
Authors will be notified if problems exist with videos as submitted, and 
will be asked to modify them if needed. No editing will be done to the 
videos at the editorial office—all changes are the responsibility of the 
author. 
Video files should be named clearly to correspond with the figure they 
represent (i.e., figure1.mov, figure2.mp4, etc.). Be sure all video files 
have filenames that are no more than 8 characters long and include the 
suffix “.mov” or ".mp4." A caption for each video should be provided 
(preferably in a similarly named Word file submitted with the videos), 
stating clearly the content of the video presentation and its relevance to 
the materials submitted. 
IMPORTANT: One to four traditional still images from the 
video must be provided. These still images may be published in the 
print edition of the article and will act as thumbnail images in the 
electronic edition that will link to the full video file. Please indicate 
clearly in your text whether a figure has a video associated with it, and 
be sure to indicate the name of the corresponding video file. A brief 
figure legend should also be provided. 
 
Review Article, Systematic Reviews and Meta-Analyses 
Abstract length: 250 words or less (structured or unstructured, 
depending on review type) 
Article length: 4,000 words or less 
Review Articles combine and/or summarize data from the knowledge 
base of a topic. Preference is given to systematic reviews and meta-
analyses of clearly stated questions over traditional narrative reviews of 
a topic.  Both types of review require an abstract; the abstract of a 
narrative review may be unstructured (no headings, run in a single 
paragraph). See below for abstracts of systematic reviews and meta-
analyses. 
The general instructions regarding submission (including cover letter, 
title page requirements, contributors' statement page, journal style 
guidance, and conflict of interest statements) also apply to Review 
Articles. 
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Systematic Reviews and Meta-Analyses 
Reports of systematic reviews and meta-analyses should use the 
PRISMA statement (http://www.prisma-statement.org/) as a guide, and 
include a completed PRISMA checklist and flow diagram to accompany 
the main text. Blank templates of the checklist and flow diagram can be 
downloaded from the PRISMA Web site (http://www.prisma-
statement.org/statement.htm). 
Structured abstracts for systematic reviews are recommended. Headings 
should include: Context, Objective, Data Sources, Study Selection, Data 
Extraction, Results, Limitations, and Conclusions (see Iverson et al
1[pp22-
23]
). 
 
Cover Letter 
The cover letter serves to assure the editors that the article and the 
authors meet the conditions of publication.  A brief paragraph that 
provides any additional information that may be useful to the editors is 
welcome, but keep in mind that the need for a long cover letter may 
indicate that the article does not speak for itself.  Reviewers will not see 
the cover letter; cover letters are not a Title Page. 
All authors are required to affirm the following in their cover letter (in 
Step Five: Details & Comments as described here) before their 
manuscript is considered: 
 That the manuscript is being submitted only to Pediatrics, that it 
will not be submitted elsewhere while under consideration, that it 
has not been published elsewhere, and, should it be published 
in Pediatrics, that it will not be published elsewhere—either in 
similar form or verbatim—without permission of the editors. 
These restrictions do not apply to abstracts or to press reports of 
presentations at scientific meetings. 
 That all authors are responsible for reported research. 
 That all authors have participated in the concept and design; 
analysis and interpretation of data; drafting or revising of the 
manuscript, and that they have approved the manuscript as 
submitted. 
If a manuscript uses the same or similar data contained in previously 
published articles, the authors must state this in the cover letter (and 
provide citations to the related or possibly duplicative materials). 
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